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Introduction
1

Chapter 1
The neuroanatomy imaging
challenge
In the last few years, a field called connectomics has garnered general in-
terest in the scientific community. However, the concept of connectomics is
not univocal. Different fields of neurobiology have their own definition of
connectomics. In particular, it is possible to divide the community into two
groups: those who analyze the functional activity of the brain and those
who study its structural organization. For the first group, connectomics
estimates and maps the functional interactions between brain regions [1].
The second group believes that connectomics consists of the reconstruction
of the anatomical network of neurons [2]. Namely, on segmenting the struc-
ture of each neuron at the level of synaptic connections through the whole
brain.
However, to understand the brain functionality it is necessary to know
its elements and their interconnections. The structural organization of the
brain affects its own mechanism, therefore, it is not possible to separate the
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anatomy from the functionality.
During the realization of this analysis it is necessary to keep in mind that
the structure of the nervous system is extraordinarily complicated. Individ-
ual neurons are interconnected to hundreds or even thousands of other cells
forming networks that can extend over large volumes. Moreover, the brain
is constituted by a great number of structurally distinct, heterogeneous, yet
interconnected components.
A deeper comprehension of the brain would have an enormous impact
for the whole society and will allow for the understanding of the neural
basis of cognition, behavior and memory. Different international projects,
such as the Human Brain Project in Europe [3] and the BRAIN initiative in
the USA [4], are now studying how the brain works. Additionally, studying
neuronal networks will permit a better knowledge of diseases, and thus, will
open the way for new treatments.
To obtain a complete map of the neuronal network, different techniques
can be used. However, since the brain architecture spans many orders of
magnitude, from the cm scale of the whole brain to the nm scale of synapses,
its 3D reconstruction requires the development of various approaches that
analyze the structure at each level.
One of the most common technique used in neuroanatomy is electron
microscopy (EM) [5]. EM obtains images at very high resolution (nm)
and permits to study specific elements of the cell nanostructure obtaining
information about how neurons interconnect to each other at the synaptic
level. Other techniques focus their attention on a bigger scale (cm). The
diffusion tensor imaging (DTI) is one of them [6]. DTI is based on the
diffusion process of water in axons and can reveal tissue architecture down
to the mm scale. Indeed, it allows for the mapping of neuronal fiber thought
the whole brain.
5Between the many techniques that address the connectomics challenge,
optical methodologies are probably the most flexible. They allow for the
reconstruction of large 3D volume providing micron-scale resolution imaging
at relatively fast acquisition rates [7].
Most of these techniques require the sample to be fluorescently labeled
[8]. Fluorescent tags have high specificity and offer the opportunity to
visualize cells and tissues at high resolution. To label a sample, fluorescence
proteins can be genetically encoded (transgenic animals) [9] or molecules can
be carried by antibodies against specific epitopes [10], moreover, dyes can
spread through the tissue with passive diffusion [11].
The first and most common approach for mapping macroscopic volume
with microscopic resolution consists of slicing fluorescently-stained samples
into thin sections and image them. The optical techniques used for imaging
are usually confocal and multiphoton microscopy. However, both of them
are not suitable for the imaging of large specimens, due to their limited
imaging depth and their long acquisition time.
To optimize these processes, automated, high-throughput imaging meth-
ods, based on serial sectioning, have been recently developed. They either
cut the sample by embedding it in hard resin and slicing it in ultra-thin rib-
bons which are imaged just after the cutting [12, 13] or by combining fixed
tissue slicing with two-photon fluorescence microscopy [14]. The major limi-
tations of these techniques are tissue deformation introduced by slicing and,
intrinsically, the destruction of the sample.
An approach that does not require sample cutting is light sheet mi-
croscopy (LSM) [15, 16, 17]. In LSM the sample is optically sectioned which
drastically reduce imaging acquisition time while achieving good resolution
at high penetration depths. However, contrarily to the other techniques it
requires the sample to be transparent. To this aim, the refractive index has
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to be homogenized inside the sample through the use of a clearing agent.
Methods for optical clearing can also be coupled with the other microscopy
techniques, which are used to speed up acquisition, increasing the imaged
volume achievable by the apparatus.
In this respect, various solutions have been used, however all of them
have different characteristics and are optimized for a specific imaging tech-
nique, preventing the possibility to use them for complementary approaches.
Correlative strategies are preferable, as they allow to overcome the inherent
limitation of every single technique and permit to span the connectomics
analysis to various scales. Indeed, a single methodology gives the answer to
just one question. The coupling of various systems permits to analyze the
same sample from different perspectives, obtaining a complete view of it.
The purpose of this thesis is to obtain a tool for studying the con-
nectomics of mouse and human brains through the combination of differ-
ent techniques and the investigation of various clearing approaches. Af-
ter studying the advantages and the disadvantages of various procedures
present in literature, the goal was achieved through the development of a
new optical clearing method for multi-modal brain imaging. This protocol
is based on a water-soluble, versatile, simple, rapid and inexpensive agent:
2,2'-thiodiethanol (TDE) [18, 19, 20].
The effectiveness of TDE in clearing mouse brain was characterized. Its
suitability with the serial two-photon tomography [14] was demonstrated.
Moreover, it was used for sample preparation in light sheet microscopy
in combination with CLARITY tissue transformation [21]. Finally, TDE
clearing was coupled with immunohistochemistry to stain a large volume
of human dysplastic brain tissue, providing the opportunity to perform a
translational analysis.
The presented strategy proposes an innovative tool for the study of con-
7nectomics. TDE clearing significantly expands the application of single-
and two-photon imaging on large samples and provides a novel and use-
ful method for quantitative morphological analysis of the neuroanatomical
structure of mouse and human brains.
To obtain a complete view of the state of the art, next chapters describe
the anatomical organization of the central nervous system (CNS) and the
major optical techniques used for imaging it. Moreover, they discuss the
advantages and the disadvantages of various clearing techniques and their
mechanisms to reduce light scattering in tissue.
8 Chapter 1. The neuroanatomy imaging challenge
Chapter 2
The central nervous system
The brain and the spinal cord constitute the central nervous system (CNS).
The CNS is a complex organ capable of storing and processing informa-
tion from a myriad of different inputs and regulating all human activity.
Neuronal tissue is specialized for the conduction of electrical impulses that
convey information or instructions from one region of the body to another.
However, how the different parts of the brain are connected still remains un-
known. This chapter analyzes the anatomical and functional characteristic
of the mouse and human central nervous system.
2.1 The cells of the nervous system
The fundamental unit of the central nervous system is the neuron, which is
a cell that consists of a cell body, called soma, and branches called dendrites
and axon ( see figure 2.1) [22, 23].
Neurons are electrically excitable cells that process and transmit infor-
mation through electrical impulses, which affect their cell membrane poten-
9
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Figure 2.1: Neuron structure Scheme showing the general structure of
a neuron. The cell body (soma) contains the nucleus and gives rise to
two types of branches: axon and dendrites. The axon is a process covered
by a fatty sheath of myelin that is interrupted at regular intervals by the
nodes of Ranvier, and transmits the electric signal. The axon of one neuron
transmits signals to another neuron at a site called synapse. The dendrites
collect information and transmit it to the cell body where it is integrated
with signals from other neurons. The image is taken from [22].
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tials and lead to chemical signals. Normally the cell membrane potential
is −70mV , and the cell is said to be polarized. When an electrical im-
pulse affects the membrane potential of a neuron's dendrite, the potential
rapidly increases causing the depolarization of the cell. If the depolariza-
tion reaches a defined threshold value it elicits an action potential. Special
types of voltage-gated ion channels embedded in the cell's membrane are
responsible for this mechanism. When the neuron is polarized these chan-
nels are shut, but they open if the membrane potential increases. In this
way, they allow for an inward flow of sodium ions, which changes the elec-
trochemical gradient of the cell raising the membrane potential. During an
action potential, the membrane potential reaches the threshold value. As a
consequence, more channels open producing a greater electric current that
travels along the entire length of the axon and transmits the signal to other
neurons [24]. This signal is self-sustained, once it is generated it will travel
across the entire length of the neuron and will transmit the information to
another cell. A single neuron can connect the different areas of the brain
even located very far away from each other. Indeed, to increase the speed
by which action potentials are conducted, axons are wrapped in a fatty,
insulating sheath of myelin produced by Schwann cells (a specific type of
glia cells). The sheath is interrupted at regular intervals by the nodes of
Ranvier in correspondence to the end of a Schwann cell and the beginning
of the next one [25].
The specialized connections where the information between neurons are
exchanged are called synapses. A synapse is a region where the axon from
the neuron transmitting the signal connects to a dendrite of the target cell.
On axons it is possible to recognize a structure called varicosity while on den-
drites there are protrusions called spine. There are two types of synapses:
electrical synapses and chemical synapses. The first type transmits directly
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the electrical impulse to other cells through channels called gap junction.
The second uses chemical mediators called neurotransmitters that activate
ion channels on the membrane of a target neuron [26]. The nerve cell trans-
mitting the signal is called presynaptic cell while the cell receiving the signal
is called postsynaptic cell.
Apart from neurons, the nervous system is composed of another class
of cells: the glial cells (glia). Glial cells have different roles in the nervous
system. Astrocytes support neurons by providing the brain structure; con-
tribute to make impermeable brain capillaries; guide migrating neurons and
direct the outgrowth of axons during the brain's development. Oligoden-
drocytes and Schwann cells remove debris and produce myelin. Microglia
cells promote efficient signaling between neurons, for example, by taking up
transmitters released in the synaptic space [27].
In the brain it is possible to identify two kinds of tissues, the gray matter
and the white matter. The gray matter contains the cell bodies of neurons
and most of it is concentrated on the surface, or cortex, of the brain. It
has a gray/brown color which comes from the capillary blood vessels and
the neuronal cell bodies. The connecting structures between various gray
matter areas of the brain form the white matter. It is composed of axonal
nerve fibers covered by myelin sheaths that give it its distinctive color. The
inner part of the brain is mostly white matter, but inside it there are also
some gray matter areas constituted by small groups of neurons, that work
as junctions along signaling pathways [23].
2.2 Central nervous system anatomy
At a larger scale, the central nervous system is divided into seven main
parts [22, 23]. They are present in both human and mouse species (fig-
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Figure 2.2: Mouse central nervous system anatomy The main struc-
tures of the mouse central nervous system are: the spinal cord, the medulla
oblongata (dark blue), the pons (green), the cerebellum (yellow), the mid-
brain (pink), the diencephalon(red), and the cerebral hemispheres (light
blue). In addition, a large part of the rostral brain is constituted of the
olfactory bulbs (brown).
ure 2.2 and 2.3). The spinal cord serves as a conduit for signals between
the brain and the rest of the body. It also controls simple musculoskeletal
reflexes without input from the brain. The medulla oblongata lies above
the upper end of the spinal cord. Besides being a conduit for fibers run-
ning between the spinal cord and other regions of the brain, it contains
control centers for involuntary functions such as blood pressure, breathing,
and digestion. Just above the medulla there are the pons and the cerebel-
lum. The pons relays information between different regions of the brain
and the cerebellum, which processes sensory information and motor skills.
The next segment, the midbrain, is primarily responsible for eye movement
and auditory reflexes. Next the midbrain lies the diencephalon, which is
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composed of two major parts: the thalamus, that processes and integrates
all information going to the cerebral cortex; and the hypothalamus, that
is critical for body homeostasis, visceral function, and endocrine function.
The highest regions of the brain are the cerebral hemispheres, which in-
clude the basal ganglia (motor performances), the hippocampus (memory
storage), the amygdaloid nuclei (emotional states), and the cerebral cortex.
Moreover, in the mouse brain, a large part of the rostral part of the brain
is dedicated to the olfactory bulbs that are involved in the sense of smell
(olfaction) [22].
The cerebral cortex is the most important structure of the gray matter,
it constitutes the outermost layer of the brain and is responsible for con-
scious sensation and voluntary movements, as well as advanced functions
such as thinking, learning and controlling emotion. It is composed of two
hemispheres that are separated by a prominent central fissure. In humans
each hemisphere is made of four lobes (see figure 2.3). The frontal lobe,
located in the front part, plays an important role in reasoning, planning,
language, memory and motor control. The parietal lobe, behind the frontal
lobe, integrates sensory information and processes visuo-spatial stimuli. The
temporal lobe, on the most lateral parts of the cortex, is involved in auditory
processing as well as language and vision related functions. The occipital
lobe occupies the rear part of the cortex and is the processing center of
visual stimuli [22] [23].
Since the cerebral cortex has such an important role, the next section
will focus on its microscopic structural anatomy.
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Figure 2.3: Central nervous system anatomy On the left scheme, the
main structures of the central nervous system are represented: the spinal
cord, the medulla oblongata, the pons, the cerebellum, the midbrain, the
diencephalon, and the cerebral hemispheres. The right schematic drawing
shows the position of the four lobes of the cerebral cortex [28].
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2.3 The cerebral cortex
The cerebral cortex is organized into six horizontal layers [29, 22], numbered
from the outer surface of the cortex to the white matter (figure 2.4).
Cortical layers contain two distinct neuronal types: pyramidal and non-
pyramidal neurons [30]. Pyramidal cells are the projection neurons of the
cerebral cortex ( i.e., neurons whose axons extend from one region to dis-
tant regions of the CNS). They have a triangular soma and a characteris-
tic dendritic arborization pattern. These cells use glutamate as excitatory
neurotransmitter. Non-pyramidal cells are the cortical interneurons, a het-
erogeneous group of cells that display a broad range of morphologies and
molecular identities. These neurons transmit signals using the neurotrans-
mitter γ-Aminobutyric acid (GABA) and also one or more neuropeptides
such as somatostatin, neuropeptide Y and cholecystokinin [31].
Individual layers have different roles and vary in relative thickness among
cortical regions. Though each cortical region has a different laminar orga-
nization, the most common is the following.
The first layer is called molecular layer. In this layer there are no cell
bodies, but it is occupied by dendrites of cells located deeper in the cortex,
and axons that travel through the layer or form connections in this layer.
The layer II is composed of interneurons. They are small spherical cells
called granule cells. This layer is called external granule cell layer. Layer
III, otherwise, is called external pyramidal cell layer, because it contains
pyramidal cells. Layer IV, like layer II, is made up primarily of granule cells
and is called internal granule cell layer. Layer V, the internal pyramidal cell
layer, contains mainly large pyramidal cells, projections and long association
outputs. Finally, layer VI is a layer constituted by heterogeneous types of
neurons and is thus called the polymorphic or multiform layer. It blends
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Figure 2.4: Layers of the cerebral cortex The cerebral cortex is orga-
nized into six cell layers. In the image, different stainings are represented,
they underline the different tissue characteristics of each layer. The Golgi
stain reveals neuronal cell bodies and dendritic trees. The Nissl method
shows cell bodies and proximal dendrites. A Weigert stain for myelinated
fibers reveals the pattern of axonal distribution. The image is taken from
[29].
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into the white matter that forms the deep limit of the cortex and carries
axons to and from the cortex [29].
Layers assume their organization during development. Stem cell pre-
cursors give rise to all neurons through differentiation and migration from
their birthplaces in the embryo to their final positions. Once the posi-
tion is reached, immature neurons organize axons and dendrites to generate
synapses [22]. The development of the cerebral cortex is a complexly orga-
nized process. Disruption of any of the steps that contribute to this process
(neuronal proliferation, migration or layer organization), can result in a
wide range of developmental disorders.
As shown in this chapter the structure of nervous tissue is very compli-
cated. Different methods should be used to study the anatomical organi-
zation of all the different networks that constitute the brain. In the next
chapter there will be a description of some of the optical techniques that
can be used for brain imaging.
Chapter 3
Optical imaging techniques in
neuroscience
One of the main methods to produce images of the brain is optical mi-
croscopy. This field has started at the end of the 16th century with Zacharias
Jansen's first microscope, and since then, many developments have been
done to increase microscopes performances and explore different contrast
mechanisms.
To make an object distinguishable from other objects within the same
field of view, it is necessary that there is a difference regarding color or
brightness, and that there is the contrast.
The main contrast mechanisms are based on transmittance (bright field
microscopy), phase shift (phase contrast microscopy) and scattering (dark
field microscopy). It is however fluorescence that, thanks to its high speci-
ficity and sensitivity, became the most popular source of contrast in biolog-
ical microscopy (Figure 3.1).
This chapter describes the physical principles of fluorescence microscopy
19
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Figure 3.1: Types of light microscopy To improve specimen contrast dif-
ferent techniques can be used. In bright field (BF) microscopy, the sample
is illuminated via transmitted white light. The dark field (DF) microscope
collects only the light scattered by the sample (the image is taken with a
red filter). Instead in phase contrast (PC) microscopy, the phase shift re-
veals index mismatch in the sample and creates changing in brightness due
to variation in refractive index in transparent samples. Fluorescence mi-
croscopy (Fluo) highlights only the labeled structures of the tissue ensuring
high specificity and sensitivity [8].
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and focuses on the most common techniques used for high-volume 3D re-
construction.
3.1 Fluorescence
Fluorescence is the spontaneous emission of light by any molecule that has
previously absorbed light. To illustrate this process, an Alexander Jablonski
diagram is routinely used (see figure 3.2) [32, 33]. A typical Jablonski
diagram graphically displays the energy states of a molecule. Electrons can
lie in different electronic states of increasing energy, for example the ground
state (S0), the first excited state (S1), and higher excited states (Sn).
Each of these electronic energy levels is divided into vibrational energy level
depicted by 0, 1, 2, etc. that are split into different rotational levels. The
transitions, that is the absorption and emission of photons between states
are illustrated as vertical lines in this graph. For each given fluorophore
there is a range of wavelengths, the excitation spectrum, that can excite it.
The energy of the absorbed photon is inversely related to the exciting
wavelength:
E =
hc
λ
(3.1)
In this equation h is Plank's constant and c and λ are the speed and
the wavelength of light in vacuum, respectively. By absorbing the energy
of the incident photon an electron of the fluorescent molecule is raised from
its ground state into an higher electronic energy level. Before the electron
decays back to S0, a fraction of the absorbed energy gets dissipated due to
internal conversion and vibrational relaxation. For that reason, the emit-
ted photon has a lower energy compared to the one that has excited the
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Figure 3.2: Jablonski's diagram Scheme depicting the spectral character-
istics related to absorption and emission of energy by a molecule. Molecules,
not absorbing energy are mainly confined to the lowest vibrational states of
the ground state S0. Each gray vertical line aligns the spectrum with the
energy of the absorbed (arrows pointing up) or emitted (arrows pointing
down) photons. The arrows are colored to represent the wavelength of the
photons. From Lichtman et al [32].
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molecule. This is called the Stokes shift and varies from one fluorophore to
another. The difference created with the Stokes shift between the exciting
and emitted wavelengths, is the property that permits the easy discrim-
ination of the generated fluorescence from the excitation light through a
dichroic filter. Therefore, it is possible to see only the objects that are
fluorescent while all the rest provides a black background.
Despite many organic substances have intrinsic fluorescence (autofluo-
rescence), fluorescence microscopy usually exploits synthesized compounds
(fluorophores) or fluorescent proteins such as GFP (green fluorescence pro-
tein). To obtain a good image it is necessary that a molecule has a high
quantum yield:
q =
kr
kr + knr
kr =
1
τr
knr =
1
τnr
(3.2)
Where kr is the rate of photons that decay with a radiative process
and knr is the rate related to non-radiative processes. They are inversely
proportional to the electron life-time (τr and τnr respectively). Electrons
of endogenous substances usually fall back to S0 without emitting fluores-
cence (non-radiative decay). On the other side, fluorophores have a high
quantum yield and permit a radiative decay. However, the fluorescence in-
tensity of a molecule is not constant. Different mechanisms such as excited
state reactions, energy transfer, complex-formation, and molecular collision
can decrease the quantity of emitted photons producing an effect called
quenching.
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Figure 3.3: PSF and resolution Point spread functions of two adjacent
points. (a) Resolved points (b) Rayleigh limit between two points (c) Un-
resolved points. Image taken from [34].
3.2 Optical resolution
The ability of an imaging system to resolve small details in the object
is quantified by resolution. This is defined as the shortest distance be-
tween two points that can still be distinguished as separate entities [8]. All
optical microscopes are limited by diffraction in the resolution they can
achieve. Diffraction is a phenomenon that occur when light encounters an
obstacle. Because in every optical imaging system light propagation is lim-
ited by finite apertures, point light sources appear as diffraction patterns.
The three-dimensional representation of this diffraction pattern is known as
point spread function (PSF).
To quantitatively define resolution there are several criteria. The most
common criteria considers two points as resolved when the maximum of the
PSF of one coincides with the first minimum of the other. This distance
(rmin) is called Rayleigh limit (see figure 3.3) and is given by:
rmin ≈ 0.6λ0
NA
(3.3)
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Figure 3.4: Numerical aperture The NA of an optical system is a number
that characterizes the angle over which the system can accept or emit light
in dependence of the refractive index of the medium. θ is the half-angle of
the maximum cone of light that can enter or exit the lens. f is the focal
length of the lens. D is the diameter of the entrance pupil. F is the focal
point. Image taken from Hecht [35].
Where the numerical aperture (NA) of a lens is defined as:
NA = n× sinθ (3.4)
Where n is the refractive index of the medium in which the lens is
working, and θ is the half-angle of the maximum cone of light that can
enter or exit the lens (figure 3.4) [35].
It is also possible to define an axial resolution (zmin), that is given by
the equation:
zmin ≈ nλ0
(NA)2
(3.5)
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However, since light detectors (such as cameras, photomultiplier tubes,
etc.) are planar, they integrate light coming from all different axial positions
in the sample. Most of the planes (basically all outside the zmin range
defined above) are out of focus, their contribute only as image blur. Systems
that are capable of discriminate light coming from different z positions are
said to perform optical sectioning, as opposite to the physical sectioning
used in standard wide-field microscopy. Microscopes performing optical
sectioning are considered in next sections.
3.3 Confocal and two-photon microscopy
The most common fluorescence technique is the wide-field microscopy. In
this kind of microscopy, a large area of the sample is illuminated with col-
limated light and the fluorescence is detected by a camera. In this way,
planes located above and below the plane conjugated with the detector are
also illuminated and out-of-focus fluorescent molecules give rise to image
blur that lowers the contrast. To avoid this effect, fluorophores excitation
should be restricted to the plane conjugated with the detector, or the system
should be able to distinguish in-focus and out-of-focus light. To this end,
various approaches have been developed. Here, the confocal microscopy and
the two-photon microscopy approaches will be discussed (figure 3.5).
3.3.1 Confocal microscopy
In confocal microscopy (CM), wide-field illumination is replaced by a fo-
cused beam [37]. The light is focused by the objective into a single spot
located in the focal plane into the specimen. The fluorescence generated
in the sample at the focal position is collected by a fast detector, usually
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Figure 3.5: Fluorescence microscopy techniques Simplified scheme of
different kinds of fluorescence microscopes. In (a) there is the wide-field flu-
orescence scheme. To obtain the information from the focal plane the whole
sample is illuminated. With the confocal approach (b) only the fluorescence
from the focal spot reaches the detector. The two-photon microscope (c)
confines the excitation to focal plane avoiding illumination of out-of-focus
areas. OL = objective lens, TL = tube lens, DM = dichroic mirror, DP =
detection pinhole. Single-photon excitation light is in blue, two-photon in
red while fluorescence emission is in green. From [36].
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a photomultiplier tube (PMT). To obtain the 2D image the laser beam is
consecutively shifted by scan mirrors to a large number of raster positions.
The most important characteristic of this microscope is the presence of a
spatial pinhole placed in front of the detector. It prevents light originating
from above or below and lateral the focal plane of the sample from reach-
ing the PMT (see figure 3.5). The elimination of out-of-focus signal leads
to the optical sectioning of the sample and enables acquisition of unblurred
images. A drawback of confocal microscopy is the strong excitation light re-
quired, that can cause fluorescence quenching. Moreover, the CM needs an
objective with a high NA for the collection of photons, and that limits the
working distance, and, therefore, the depth achievable with this technique.
3.3.2 Two-photon fluorescence microscopy
Two-photon fluorescence microscopy (TPFM) is based on the principle that
the excitation of a fluorophore can be achieved by the nearly simultaneous
absorption of two photons of about half of the energy required for single-
photon excitation. The probability of two-photon absorption is quadrati-
cally dependent on the intensity of the incident light. To generate sufficient
signal, excitation light intensity has to be concentrated in space and time
and this occurs only in the focal plane. Away from the focus, the probabil-
ity drops off rapidly so that elsewhere in the sample the excitation is very
unlikely (see figure 3.5 and 3.6, [38, 39]). Indeed, only ballistic photons lead
to fluorescence, there is no background and, therefore, the excitation light
can penetrate deep into the specimen to the plane of focus.
The lack of out-of-focus excitation in non-linear microscopy carries to a
spatial resolution that is nearly identical to the one of confocal microscopy
without the use of a pinhole. The long wavelengths (infrared region, IR)
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(a) Jablonski diagrams
(b) Excitation volume
Figure 3.6: Localization of fluorescence by two-photon excitation (a)
Jablonski diagram of one-photon (left) and two-photon (right) excitation.
One-photon excitation occurs through the absorption of a single photon.
Two-photon excitation occurs through the absorption of two lower-energy
photons via a virtual state. From [39]. (b) On the left, single-photon
excitation of fluorescein by focused 488 nm light. On the right, two-photon
excitation using focused femtosecond pulses of 960 nm light. From [38].
30 Chapter 3. Optical imaging techniques in neuroscience
used in TPFM are generally less phototoxic to living tissue and lead to
a less quenching. Moreover, in the IR region biological tissues are more
transparent allowing to reach higher imaging depth compared to CM. Con-
sequently, the maximum depth achievable in living animals is ∼800µm [39].
However, it drastically decreases in fixed samples (300µm) [40]. That limits
the imaging analysis of high volume samples such as the whole mouse brain.
3.4 Serial sectioning methods
The growing need of obtaining whole-brain reconstruction has led to the
development of new approaches that combine different techniques. One
method consists in obtaining automatic microscopes for large datasets anal-
ysis based on the integration of imaging and tissue sectioning.
It is possible to distinguish two similar processes based on the micro-
scope used. One of them is micro-optical sectioning tomography (MOST
and fMOST for fluorescence microscopy) [12, 13] that uses a single-photon
microscope coupled with tissue serial sectioning. Another is the serial two-
photon (STP) tomography [14], it combines two-photon fluorescence mi-
croscopy with the serial sectioning of the sample.
These methods are characterized by the presence of automated high-
throughput instrumentation. In particular, a motorized platform is present
under microscope objective for moving the sample allowing top-view mosaic
imaging. Before every cycle of acquisition, a sectioning step is performed
followed by a mechanical removal of the imaged tissue.
Samples preparation is different between the two techniques. In fMOST
the brain is embedded in a hard resin that allows to cut the sample in ultra-
thin sections (1 µm) with a diamond knife (figure 3.7). In this technique, the
preparation of the sample requires time and effort but permits very precise
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cuts. The absence of distortions avoids alignment problems and guarantees
a complete reconstruction of the whole brain.
Instead, in STP, the brain is fixated with paraformaldehyde. This al-
lows for embedding the tissue in agar and performing the sectioning with
a vibratome (figure 3.7). This approach doesn't require specific efforts in
preparing the sample, however, it presents a disadvantage. Due to tissue de-
formations introduced by slicing, imaging can't be done near the tissue cuts.
It is preferable to image 50 µm below every cut. Moreover, since the tis-
sue is fixed, the imaging penetration depth achievable with the two-photon
fluorescence microscope is few hundreds of µm. To obtain the complete
reconstruction of large volumes in a relatively short time (hours to days in
dependence of the resolution) Ragan et al. [14] found a compromise be-
tween slicing and imaging. Whole brain tomography was obtained cutting
every 100 µm and imaging 50 µm below the tissue surface, leading to the
95% loss of information.
Although these approaches allow big sample reconstruction with very
high resolution (figure 3.8), they require long acquisition times (days up
to weeks). Furthermore, these techniques intrinsically destroy the sample
during imaging.
To overcome these downsides another approach, that does not require
sample cutting, can be used: the light sheet microscopy (LSM).
3.5 Light-sheet microscopy
Light-sheet microscopy (LSM) is a fluorescence microscopy technique that
uses a thin sheet of light to illuminate the specimen, performing optical
sectioning instead of physical sectioning [15, 16, 42, 43]. In detail, during
LSM the sample is illuminated with a thin sheet of light confined in the focal
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Figure 3.7: Serial sectioning methods (a) In STP tomography, a two-
photon microscope is used to image the coronal plane of the mouse brain,
afterwards a microtome sections off the imaged tissue. A piezo objective
scanner can be used for z-stack imaging. (b) In fMOST, a confocal line-scan
microscope is used to image 1-µm thin section of the brain previously cut
by a diamond knife [41].
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Figure 3.8: STP tomography (a) 3D view of a coronal section of the
GFPM brain imaged with a 20× objective at 0.5 µm XY sampling. (b-c)
Enlarged views from regions (i) and (ii) in panel, respectively, demonstrating
visualization of dendritic spines and fine axon fibers; scale bar = 5 µm.
Image taken from [14].
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plane of the detection objective. The fluorescence emission is collected along
an axis perpendicular to the illumination plane (figure 3.9). The optical
paths of excitation and detection light are decoupled guaranteeing optical
sectioning also with low-NA optics (axial resolution is given by the thickness
of the light sheet). Moreover, with this approach, fluorophores are excited
only at the focal plane of the detection objective, dramatically reducing the
photobleaching compared to confocal microscopy.
The detection architecture is similar to the one of wide-field microscopy,
making the acquisition faster compared with confocal and two-photon mi-
croscopy. Moving the sample through the light sheet permits to obtain a
complete tomography of big specimens, such as whole mouse brains, in some
hours. This technique drastically reduces acquisition time and achieves good
resolution at high penetration depths. However, it requires the sample to
be transparent. To allow imaging at high depths it is necessary to reduce
light scattering and make the tissues transparent. This goal can be achieve
homogenizing the refractive index inside and outside the sample by using
clearing agents.
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Figure 3.9: Light sheet illumination microscope scheme Excitation
(in blue) and emission (in green) pathways are orthogonal to each other.
The light sheet lies in the focal plane of the detection objective. Image
taken from [42].
36 Chapter 3. Optical imaging techniques in neuroscience
Chapter 4
Clearing methods
The inherent three-dimensional (3D) structure of cells and organs requires
volumetric imaging. To investigate structure, different techniques, such as
serial two-photon sectioning and light sheet microscopy, can be used. They
allow 3D reconstruction of large specimens at high resolution, however, they
are limited by light scattering. In fact, normally, light does not propagate
well inside tissues because of scattering, making imaging of large tissue
problematic. To improve imaging depth samples should be as transparent
as possible. A large number of approaches have been developed that clear
tissues to reduce scattering. This chapter describes the mechanism of light
scattering and the clearing techniques that make tissues transparent and,
therefore, are used for large volume 3D reconstruction.
4.1 Scattering and refractive index
Scattering is the event that occurs when the propagation of light rays de-
viate from their straight path when they encounter irregularities in the
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propagating medium [44]. To clear samples is necessary to assure that all
wavelengths pass "through" the tissue minimizing scattering. Scattering
occurs when the refractive index between different regions of the sample is
heterogeneous. In particular, this event limits the penetration of the light
deep into the tissue when the variation of the refractive index is similar to
the wavelength of the light used for imaging [45, 35, 46].
To reduce scattering and to make the tissue transparent, the refractive
index has to be homogenized inside and outside the sample (figure 4.1). To
this end different approaches have been developed based on organic solvents,
aqueous solvents and tissue transformation.
4.2 Organic agents
Large tissue optical clearing was achieved for the first time by Spalteholz
in 1914 [47] (table 4.1). His approach was based on two steps: a dehy-
dration step (based on ethanol), that removes water from the tissue, and
a clearing step with high refractive index organic solvents (benzylbenzoate
and methylsalicilate), that achieves the final transparency. A drawback of
this technique is the shrinkage of the tissue caused by the dehydration step.
The diffusion of water is faster than the one of ethanol. Moreover, after
clearing, the tissue is hard and difficult to cut and proteins fluorescence is
not well preserved.
Subsequently, trying to preserve sample fluorescence, other clearing meth-
ods, based on the same principle, have been proposed. In 2007 Dodt et al.
[16], used the combination of ethanol and BABB (benzylalcohol / benzyl-
benzoate) to perform three-dimensional visualization of neuronal networks
in whole mouse brain with light sheet microscopy, yet fluorescence was main-
tained in the samples for only one day.
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Figure 4.1: Light scattering and refractive index matching (a) Scat-
tering occurs when the refractive index between different regions of the
sample is heterogeneous (n1 6= n2). (b) Scattering is strongly reduced and
light can pass through the tissue when the sample and the surrounding
medium have similar refractive indexes (n1 = n2). (c) and (d) Schematic
drawing showing a brain before and after optical clearing.
40 Chapter 4. Clearing methods
Dehydration Clearing n Transparency Fluorescence Ref
Ethanol Benzylbenzoate 1.56 Yes No [47]
Ethanol BABB 1.54 Yes Yes/1day [16]
THF DBE 1.56 Yes Yes/2days [48]
Table 4.1: Comparison between organic solvents based methods
The clearing is obtained in two steps: the first step of dehydration removes
water from the tissue. Subsequently, the clearing step with high refractive
index organic solvents achieves the final transparency. In the table there
are the major agents used to clear mouse brains. BABB = benzyl alcohol
/ benzyl benzoate, THF = tetrahydrofurane and DBE = dibenzyl ether.
To prolong this time, Becker et al. in 2012 [48], tested different GFP-
friendly dehydration and clearing solutions. They analyzed dehydration
mediums such as ethanol, methanol, acetone, 2-butoxyethanol, dimethyl-
formamide, dimethylsulfoxide (DMSO), tetrahydrofurane (THF) and diox-
ane, and clearing solution such as dibenzyl ether (n=1.56), methylsalicy-
late (n=1.51), benzyl alcohol (n=1.54), benzyl benzoate (n=1.56), trans-
anethole (n=1.56), isoeugenol (n=1.57), isosafrol (n=1.57), 1,5- dibromopen-
tane (n=1.51), and bromobenzene (n = 1.56). They concluded that the best
clearing procedure, allowing fluorescence preservation up to two days, com-
bines tetrahydrofurane (THF) and dibenzyl ether (DBE) (see figure 4.2),
this technique was called 3DISCO [49]. Subsequently, the iDISCO method
[50] combined the protocol with whole tissue immunostaing, avoiding the
necessity of protein fluorescence preservation.
All these methods are used because they guarantee high transparency,
they are easy to perform and very fast, and can be applied to different
tissue types [16]. However, they have some disadvantages that limit their
applicability. They lead to a fast protein fluorescence quenching (few days),
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Figure 4.2: 3DISCO clearing (a) (b) A mouse brain before and after
3DISCO clearing: the method achieves a high transparency. (c) The 3D re-
construction of a GFP-M mouse brain imaged with a light sheet microscope.
Image modified from [49].
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tissue alteration and shrinkage (sometimes of up to 50% [48]), moreover the
majority of them have the capacity to dissolve glues used in the construction
of objective lenses. For these reasons other approaches have been studied
based on aqueous solutions.
4.3 Aqueous agents
The idea of using aqueous solutions for tissue clearing was born from the
observation that dipping specimen in solution of glycerol and water (80% n
= 1.44), routinely used for tissue mounting, leads also to sample clearing.
This is true only for thin sample slices, but allows for the preservation of
sample fluorescence. From this observation, to prevent protein fluorescence
quenching, other approaches involving water-based optical clearing agents
were developed. Among the first, there was the Scale procedure [51]. Scale
utilizes urea for the hyper-hydration of the tissue. During the clearing step,
urea can enter tightly folded regions of high refractive index proteins, creat-
ing an osmotic gradient that pulls water. This partially denatures proteins,
hydrates them, and decreases the overall refractive index of the tissue. A
similar approach was proposed in 2013: the ClearT method [52]. It is based
on a urea-like molecule (formamide) as active clearing reagent, which leads
to hyper-hydration. Both of these techniques lead to fluorescence preser-
vation, however, they lead also to massive tissue swelling and subcellular
structure alterations (figure 4.3). Moreover, transparency is only achieved
in tissue slides or in brain of newborn mice (up to 5 days) but not in the
entire brain of adult mice.
Subsequently, another protocol based on the simple immersion of the
tissue in a high refractive index aqueous solution was published, the SeeDB
method [53]. It is based on saturated fructose solutions that achieve a n =
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Figure 4.3: Comparison between SeeDB and Scale clearing (a) Adult
1.5 mm thick mouse brain slices before and after SeeDB and Scale clear-
ing (transmission images). White matter is fully cleared with SeeDB, but
not with Scale, moreover Scale produces a swelling of the tissue. (b) Im-
age of neuron after clearing. In Scale-treated samples, it is possible to see
morphological changes, dendrites appear serrated (yellow arrowheads), sug-
gesting damages as a result of anisotropic sample volume changes. On the
contrary, SeeDB-treated samples have a smooth appearance. Scale bars, 50
µm. Image modified from [53].
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1.49. Fructose is not toxic, compatible with protein fluorescence and doesn't
alter tissue structure (see figure 4.3). However, highly concentrated sugar
solutions are difficult to manage due to their high viscosity and require long
incubation times. Moreover, with this technique it is not possible to clear
a whole adult mouse brain.
As a compromise between hyper-hydration and SeeDB other protocols
were studied. The CUBIC method [54, 55], utilizes a hyper-hydration urea-
based mechanism, but includes a high refractive index sucrose solution in
the clearing process. However, to remove lipids and obtain transparent
samples, it also uses very high levels of triton (50%) that result in protein
loss (24%-41%), which lowers epitopes concentrations and weakens possible
immunostaining. The same approach was used in the FRUIT techniques
[56], that combine SeeDB and Scale techniques by mixing urea with fructose,
and by the ScaleS [57] that uses urea and sorbitol. Both lower the overall
viscosity of the SeeDB fructose solution, however, they can't achieve whole
mouse brain transparency.
Although aqueous techniques improve protein fluorescence preservation
and are not toxic, they do not clear as well as the organic methods, limiting
the quality of the acquired images.
4.4 Tissue transformation
Biological tissues, such as brain, are constituted by cells. Each cell com-
partment is bound by a membrane, consisting of a lipid bilayer. The lipid-
aqueous interface contributes to creating heterogeneity in the refractive
index and leads to light scattering. Moreover, these structures create a
diffusion barrier that renders tissue poorly accessible to molecules. The
penetration by chemicals and photons is fundamental in optical biology for
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sample labeling and imaging.
Recently, based on these considerations, a new approach called CLAR-
ITY was developed [21, 58]. It addresses the challenge of producing large,
transparent and fluorescently labeled volumes through tissue transforma-
tion. The method removes cell lipid bilayers and allows light and macro-
molecules to penetrate deep into the tissue, permitting three-dimensional
imaging and immunohistological analysis. To provide structural integrity
and retain biomolecules, CLARITY transforms the tissue into a nanoporous
hydrogel-hybridized lipid-free form. The procedure is divided into four steps
represented in figure 4.4.
The first step consists in the animal perfusion at 4◦C with the hydro-
gel monomers (acrylamide and bisacrylamide), formaldehyde and the ther-
mally triggered initiator. In this step, formaldehyde crosslinks the hydrogel
monomers to biomolecules that have a reactive group (the amino group),
such as proteins and nucleic acids.
The temperature is fundamental, in fact, in the second step, the poly-
merization of the biomolecule-conjugated monomers is triggered by increas-
ing it. Tissue incubation at 37◦C permits to obtain the hybridization of
the tissue with the hydrogel. This construct physically supports tissue
structure and chemically incorporates biomolecules. Importantly, lipids and
biomolecules lacking functional groups for conjugation remain unbound and,
therefore, can be removed.
Lipids extraction is carried out in the third step by electrophoretic tis-
sue clearing (ETC). ETC is based on the active transport of ionic micelles
through the tissue. Lipids are incorporated within micelles and removed
from the specimen. The hydrogel is highly permeable, which allows im-
munohistochemistry, facilitating tissue labeling. As a final step, the refrac-
tive index matching solution FocusClearTM , a very expensive solution, is
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Figure 4.4: CLARITY protocol Scheme showing the different steps of the
CLARITY method. The first step consists in the perfusion of the sample
with formaldehyde and hydrogel monomers. The hydrogel-tissue hybridiza-
tion occurs in the second step while in the third lipids are extract with
an electrophoretic field. After that, the brain is ready for refractive-index
matching and imaging. Reproduced from [21].
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Figure 4.5: Multiround immunostaining CLARITY enables multi-
round molecular phenotyping. The permeability of clarified tissue facili-
tates rapid antibody exchange. Antibodies removal is performed with the
ionic detergent used initially to create clarified tissue. The solution dena-
tures antibodies and disrupts binding without structural damage or antigen
degradation. After that new round of immunostaining can be performed.
Reproduced from [21].
used to clear the sample. Imaging of cleared samples can be performed with
any fluorescence microscopes. In the paper they used a confocal microscope
(figure 4.6).
CLARITY is compatible with immunostaining. Indeed, without mem-
brane lipids, antibodies can penetrate deep into tissue, allowing large brain
tissue labeling. Chung et al. spread the applicability of this technique
adding a multiround labeling that permits to analyze different epitopes of
the same sample, opening the door for new approaches (figure 4.5 and 4.6).
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Figure 4.6: Whole mouse brain imaging (a) Images made with a con-
focal microscope of a Thy1-eYFP line-H mouse brain after CLARITY
hydrogel-tissue hybridization, ETC, and refractive-index matching. (b)
Three-dimensional view of mouse hippocampus showing eYFP expressing
neurons (green), parvalbumin-positive neurons (PV, red) and astrocytes
(GFAP, blue). Scale bar = 200 mm. Reproduced from [21].
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However, CLARITY has some disadvantages. Focus ClearTM is very
expensive and that limits its practical applicability on routine experiments
(e.g. since 1ml costs 20$, a whole mouse brain clearing can cost up to
2000$), moreover its composition is unknown due to patent protection.
Similar to this method, another technique called PACT ( PAssive CLAR-
ITY Technique), that uses a Refractive Index Matching Solution (RIMS)
to clear samples [59], was published. To achieve whole brain clearing and
labeling they also developed PARS ( Perfusion-assisted Agent Release in
Situ) that delivered the PACT reagents perfusing animals. All of them are
based on quick lipid removal and utilize a low-viscosity, high refractive in-
dex contrast reagent: the Histodenz, a diatrizoic acid based compound. As
with the CLARITY protocol, also these methods require a long preparation
time (weeks) and complicated procedures, but, in addition, they have the
disadvantage of haven't been used for human brain analysis. Since, PACT
derived from CLARITY and PARS needed to perfuse samples, in this work
the CLARITY method was used as starting procedure to prepare mouse
and human brain samples for both two-photon and light sheet imaging.
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Part II
Methods
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Chapter 5
Sample analysis: clearing and
imaging techniques
As presented in the first part, to improve the imaging deep achievable with
fluorescence microscopy it is necessary to make the tissue transparent. The
present chapter provides an overview of the specimens used in this research,
the protocols employed to make them clear and the fluorescence microscopy
techniques used to image them.
5.1 Transgenic animal models
Different lines of transgenic mice were analyzed; for the sparse labeling
of pyramidal neurons with GFP the Thy1-GFP-M line was used [60]. For
the visualization of GABAergic interneurons GAD2-ires-Cre-tdTomato mice
were used [61] and for imaging the subpopulation of parvalbumin-positive
interneurons the PV-Cre-tdTomato line was used [62]. For the analysis of
all Purkinje cells of the cerebellum the L7-GFP mice were used [63]. The
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experimental protocols involving animals were designed in accordance with
the laws of the Italian Ministry of Health.
5.2 Human brain specimen collection
Human brain samples were removed during a surgical procedure for the
treatment of drug-resistant epilepsy in a child with hemimegalencephaly
(HME). The sample was obtained after informed consent, according to the
guidelines of the Human Research Ethics Committee of the A. Meyer Chil-
dren's Hospital. Upon collection, the sample was placed in neutral buffered
(pH 7.2-7.4) formalin (Diapath, Martinengo, Italy) and stored at room tem-
perature.
5.3 Organic solvent clearing
This section describes the protocol used to prepare mouse brain samples for
light sheet microscopy analysis. It is based on organic solvent clearing and
consists in three step: sample fixation, clearing and imaging.
5.3.1 Preparation of PFA-fixed mouse brains
The following protocol was used to fix mouse brain samples before organic
solvent clearing (with BABB and DBE). As described in the next section
(5.4) it was used also for aqueous solution clearing (SeeDB and TDE).
Adult mice were deeply anesthetized with an intraperitoneal injection
of ketamine (90 mg/kg) and xylazine (9 mg/kg). They were transcardially
perfused with 100 ml of ice-cold 0.01 M phosphate buffered saline (PBS)
solution (pH 7.6), followed by 100 ml of freshly prepared ice-cold parafor-
maldehyde (PFA) 4% in 0.01 M PBS (pH 7.6).
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The brain was extracted from the skull and fixed overnight in 20 ml of
PFA 4% at 4◦C. Samples were then rinsed three times (30 minutes each) in
20 ml of 0.01M PBS at 4◦C. The brains were stored in 20 ml of 0.01M PBS
at 4◦C.
For transmission electron microscopy (TEM) the anesthetized animal
was perfused with 10 ml of PBS immediately followed by 300 ml of a mixture
of 2.5% glutaraldehyde (Glut) and 2% PFA in 0.01 M phosphate buffer (pH
7.4). After 2 hours, the brain was removed and stored at 4◦C in 50 ml of
0.01M PBS.
5.3.2 Organic solvent optical clearing
Optical clearing of murine PFA-fixed brains with organic solvents was per-
formed in two steps: the dehydration and the clearing step (see figure 5.1).
The dehydration step was performed either with ethanol or tetrahydrofu-
ran (THF). The clearing was achieved with benzyl alcohol/benzyl benzoate
(BABB) or dibenzyl ether (DBE) following the protocol of Dodt et al. [16]
and Becker et al. [48].
Dehydration was achieved with serial incubation in 20 ml (vol/vol) so-
lutions of ethanol/water or THF/water 50%, 70%, 80%, 90%, 96%, 100%
for 1 hour each, then 100% overnight. Incubations were made on a rotating
wheel at room temperature (RT).
For clearing the sample was put in 20 ml of 100% BABB (1 part of
benzyl alcohol and 2 parts of benzyl benzoate) or 100% DBE for 1 day
at RT while rotating (the solution is changed at least 1 time during the
incubation).
THF, BABB and DBE solutions can carry peroxides that destroy protein
folding and lead to fluorescence bleaching. To avoid it, peroxides were
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Figure 5.1: Organic solvent clearing The approach is based on two steps:
a dehydration step, that removes water from the tissue, and a clearing step
with high refractive index organic solvents, that achieves the final trans-
parency. Image modified from [64].
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removed from solutions with an aluminum oxide filtration (250 g of alumin
oxide per liter, see figure 5.2) before the clearing procedure.
Peroxide filtration in THF leads to the removing of THF stabilizer. This
stabilizer is required to prevent THF explosion. Therefore, it is substituted
by adding 250 mg/l butyl hydroxyltoluol (BHT) into the receiver flask.
5.3.3 Imaging with light-sheet microscopy
Specimens were imaged using a custom-made light sheet microscope (LSM)
described in Silvestri et al [65]. Briefly, in this LSM the light sheet is
generated using a laser beam scanned by a galvanometric mirror (VM2500+,
Cambridge Technology); a de-scanning system in the detection path creates
a fixed image of the excitation scanning line in a secondary image plane,
where a linear spatial filter (slit, p/n 35290NR, JML Optical) is positioned.
A third scanning system reproduces a wide-field-like image on the chip of
an EMCCD camera (Cascade II: 512, Photometrics). The laser light was
provided by a diode laser (Excelsior 488, Spectra Physics), λ = 488 nm. An
acoustic-optic tunable filter (AOTFnC-400.650-TN, AA Opto-Electronic)
was used to regulate laser power. The sample was mounted on a tipped
plate and placed in a custom-made chamber which allowed brain tissue
being immersed in clearing solution during imaging. A motorized stage
allowed 3D motion of the sample, as well as rotation around the vertical axis
(three M-122.2DD and one M-116.DG, Physik Instrumente). An achromatic
doublet (CVI Melles Griot, focal length 50 mm) was used for illumination,
while the objective lens used for detection was a 20× Nikon Plan SLWD
(NA 0.35, WD 24 mm). The slit aperture was set to 15 µm.
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Figure 5.2: THF, BABB and DBE filtration (a) Scheme showing the
apparatus for THF peroxide removal. Since THF is volatile the system is
closed. The solution is placed in a dropping funnel with pressure compen-
sation (1). A chromatography column filled with aluminum oxide filters the
solution (2) that is collected in a round bottom flask (3). A drying tube
(4), filled with calcium chloride, absorbs water vapor. (b) Scheme showing
the apparatus for BABB and DBE peroxide removal. The filter unit (1)
consists of aluminum oxide powder and filter paper (16-40 µm pore size). A
vacuum tight filtering flask collects the solution after filtration (2). Image
taken from [48]
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5.4 TDE clearing for two-photon imaging
TDE can be used directly on PFA-fixed sample. This clearing protocol
combined with serial two-photon sectioning allowed for the reconstruction
of large samples. This section describes the two-photon fluorescence micro-
scope used for the characterization of TDE direct clearing and analyzes the
system to perform serial two-photon tomography.
5.4.1 Direct TDE clearing
Mouse brain samples were perfused with PFA as described in 5.3.1, then
they were cleared with serial incubations in 20 ml of 20% and 47% (vol/vol)
2,2'-thiodiethanol in 0.01M PBS (TDE/PBS), each for either 1 hour at
37◦C or for 12 hours at room temperature (RT) while gently shaking. After
clearing they were ready to be imaged.
5.4.2 Two-photon fluorescence microscopy
The custom-made two-photon fluorescence microscope (TPFM) (figure 5.3,
described in [66]) was constituted by a mode locked Ti:Sapphire laser (
Chameleon, 120 fs pulse width, 80 MHz repetition rate, Coherent, CA)
coupled into a custom-made scanning system based on a pair of galvano-
metric mirrors (VM500+, Cambridge Technologies, MA). The laser was
focused into the specimen by a water immersion 20× objective lens (XLUM
20, NA 0.95, WD 2mm, Olympus, Japan) for uncleared (PBS) sample imag-
ing or a tunable 20× objective lens (Scale LD SC Plan-Apochromat, NA
1, WD 5.6mm, Zeiss, Germany) and a tunable 25× objective lens (LD
LCI Plan-Apochromat, NA 0.8, WD 0.55mm, Imm Corr DIC M27, Zeiss,
Germany) for cleared (47% TDE/PBS) sample imaging. The system was
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Figure 5.3: Two-photon fluorescence microscope (TPFM) Sim-
plified scheme showing the TPFM apparatus. Obj = objective, GM
=galvanometric mirror, DM =dichroic mirror, FF = fuorescence filter, PMT
= photomultiplier tube, Piezo = piezoelectric stage. Two-photon excitation
light is in red while fuorescence emission is in green and cyan. Image mod-
ified from [66].
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equipped with a motorized xy stage (MPC-200, Sutter Instrumente, CA)
for lateral displacement of the sample and with a closed-loop piezoelectric
stage (ND72Z2LAQ PIFOC objective scanning system, 2mm travel range,
Physik Instrumente, Germany) for the displacement of the objective along
the z axis. The fluorescent light is separated from the laser optical path by
a dichroic beam splitter (DM1) positioned as close as possible to the objec-
tive lens (non-de-scanning mode). A two-photon fluorescence cut-off filter
(720 SP) eliminates reflected laser light. A second dichroic mirror (DM2)
is used to split the two spectral components of the fluorescence signal. The
fluorescence signals are filtered with 630/69 and 510/42 filters (FF1 and
FF2) and collected by two orthogonal photomultiplier modules (H7422P,
Hamamatsu Photonics, Japan). The instrument was controlled by custom
software, written in LabView (National Instruments, TX).
5.4.3 Serial two-photon tomography
The two-photon fluorescence microscope was coupled with a vibratome (Vi-
bratome 1000 Plus, Intracel LTD, UK) to perform a serial two-photon to-
mography of a Thy1-GFP-M hippocampus. The hippocampus was manu-
ally dissected from a PFA-fixed adult (p56) mouse brain and cleared by two
serial incubations in 20 ml of 20% and 47% (vol/vol) TDE/PBS, each for
1 hour at 37◦C while gently shaking. After clearing, the hippocampus was
embedded in a solution of 47% TDE/PBS (vol/vol) - agar 4% (wt/vol). In
order to reduce the number of slices required, the hippocampus was horizon-
tally oriented with respect to the optical planes acquired. Serial sectioning
was performed with the vibratome and after every cut the sample was left
in 47% TDE/PBS overnight at RT. Stacks of each layer were acquired with
the TPFM (Zeiss 20× Scale objective, pixels size 0.59 × 0.59 µm2) using
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a custom LabView program (National Instruments) allowing for automatic
acquisition of adjacent regions drawing a spiral square. Each stack had a
depth of 1000 µm with a z displacement of 4 µm between images. Each
frame had a field of view of 300 × 300 µm2, adjacent stacks had an over-
lap of 30 µm. To ensure an efficient 3D reconstruction along the z axis,
slicing was performed every 800 µm such that the subsequent layer had an
overlapping region of 200 µm with the previous one. To obtain constant
fluorescence intensity, laser power was increased during acquisition accord-
ing to the imaging depth, however, some illumination inhomogeneity were
present due to the inherent heterogeneity of the tissue.
5.5 CLARITY - TDE clearing for light sheet mi-
croscopy
To perform light sheet microscopy, TDE clearing was combined with the
CLARITY method. This section describes the protocol used to prepare
mouse brain samples for LSM analysis. It consists of different steps: CLAR-
ITY fixation, sample labeling, TDE clearing and LSM imaging.
5.5.1 Preparation of CLARITY-processed mouse brains
CLARITY mouse brains were prepared according to the Chung protocol
(figure 4.4) [21]. Samples were then cleared with either FocusClearTM or
TDE allowing LSM imaging.
Adult mice were anaesthetized with isofluorane and transcardially per-
fused with 20 ml ice-cold PBS solution (pH 7.6) followed by 20 ml of a
mixture of 4% (wt/vol) PFA, 4% (wt/vol) acrylamide, 0.05% (wt/vol) bis-
acrylamide, 0.25% (wt/vol) VA044 in PBS.
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Brains were extracted and incubated in the same solution at 4◦C for 3
days. The samples were then degassed and the temperature was increased to
37◦C to initiate polymerization. The embedded sample was extracted from
the gel and washed with clearing solution at 37◦C through gentle shaking.
To perform electrophoretic tissue clearing (ETC), hydrogel-embedded
brains were placed in a custom-built organ-electrophoresis chamber (see
figure 5.4). Sodium borate buffer (200 mM, pH 8.5) containing 4% (wt/vol)
sodium dodecyl sulfate (SDS) was circulated through the chamber and a
voltage of 20V was applied across the ETC chamber at 37◦C for several
days.
After clearing, brains were incubated in PBST0.1 (PBS and 0.1% Triton
X-100, pH 7.6) at 37◦C for 2 days to remove the SDS.
For vasculature staining, a specialized CLARITY perfusion protocol was
applied. It was developed in collaboration with J.P Ghobril from the Lab-
oratory of Neural Microcircuitry, Brain Mind Institute, EPFL, Lausanne,
Switzerland.
Mice were anesthetized with pentobarbital (150 mg/kg) and transcar-
dially perfused with PBS and 10ml of CLARITY monomer solution. After
this, a third perfusion was performed with 20 ml of the monomeric solution
containing FITC-albumin at 4mg/ml.
During polymerization the fluorescent albumin tightly integrated into
the acrylamide mesh and was therefore not eliminated during lipid removal.
5.5.2 Sample labeling and optical clearing
Mouse brain samples treated with CLARITY were optically cleared with
serial incubations in 50 ml of 30% and 63% (vol/vol) 2,2'-thiodiethanol in
0.01M PBS (TDE/PBS), each for 1 day at 37◦C while gently shaking before
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Figure 5.4: CLARITY-ETC apparatus Photo of the custom-made elec-
trophoresis apparatus. The sample is placed inside a plastic chamber, lipids
are extracted from tissue with an electric field created by a power supply.
Electrodes (made with platinum wires) are placed inside the chamber on
sides and are linked with the power supply, negative and positive wires
are respectively black and red. The clearing solution flow is controlled by
the temperature controlled water circulator that is set at 37◦C. The solution
before entering again in the chamber passes trough a filter for lipid removal.
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imaging with a light sheet microscope.
For whole brain nuclei staining, CLARITY-processed murine samples
were incubated at 37◦C for 2 days with 1:50 Propidium Iodide (PI, LifeTech-
nologies, CA, P3566) solution, in PBST0.1 followed by washing at 37
◦C for
1 day in PBST0.1 solution.
5.5.3 TDE-CLARITY sample imaging with light-sheet mi-
croscopy
Specimens were imaged using a custom-made light sheet microscope (LSM)
described in Müllenbroich et al. [67] (see figure 5.5). The light sheet was
generated by scanning the excitation beam with a galvanometric mirror
(6220H, Cambridge Technology, MA) and confocality was achieved by syn-
chronizing the galvo scanner with the line read-out of the sCMOS camera
(Orca Flash 4.0, Hamamatsu Photonics, Japan). Five different wavelengths
were available (MLDs and DPSSs, Cobolt, Sweden) for fluorescence excita-
tion and an acousto-optic tunable filter (AOTFnC-400.650-TN, AA Opto-
Electronic, France) was used to regulate laser power. The excitation light
was focused with a long working distance, low magnification objective (10×,
0.3 NA, WD 17.5mm, Nikon, Japan) and fluorescence was collected on a
perpendicular axis with a specialized objective for high refractive index im-
mersion solutions with a correction collar for refractive indexes ranging from
1.41 to 1.52: the 25× Olympus objective (XLSLPLN25XGMP, 25×, 1.0 NA,
WD 8mm Olympus, Japan). The samples were mounted on a motorized
x-, y-, z-, φ -stage (M-122.2DD and M-116.DG, Physik Instrumente, Ger-
many) which allowed free 3D motion plus rotation in a custom-made cham-
ber filled with 63% TDE/PBS. The microscope was controlled via custom
written LabVIEW code (National Instruments) using the Murmex package
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Figure 5.5: Light sheet microscope (LSM) Simplified scheme showing
the LSM apparatus. (a) Scheme of the light path. LP: long-pass filter,
I: iris, AOTF: acousto-optical tunable filter, LM: laser modulator, PBS:
polarization beam splitter. Green dotted: detection path. (b) Oblique view
of the microscope. Image taken from [67].
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(Distrio, The Nederlands) which coordinated the galvo scanners, the rolling
shutter and the stack acquisition.
5.6 TDE passive CLARITY methods for human
brain analysis
For translational analysis, a passive CLARITY (PC) protocol was optimized
using Chung et al. [21] as a starting point. It was used in combination with
an immunohistochemistry protocol and TDE clearing. This method allowed
sample imaging with two-photon fluorescence microscopy described in 5.4.2.
This section describes the preparation of the sample, the staining and the
clearing. The PC protocol has been applied to Thy1-GFP-M mouse brain
slices and a human brain bioptic sample.
5.6.1 Preparation of passive CLARITY samples
Blocks of fixed samples were washed in PBS at 4◦C for one day and then
incubated in 4% (wt/vol) PFA, 4% (wt/vol) acrylamide, 0.25% (wt/vol)
VA044 in PBS at 4◦C for 2 weeks.
Samples were degassed and then the temperature was increased to 37◦C
to initiate polymerization. The embedded samples were extracted from the
gel and incubated in clearing solution (sodium borate buffer 200 mM, pH
8.5) containing 4% (wt/vol SDS) at 37◦C for two weeks while gently shaking.
After lipids removal, samples were incubated in PBST0.1 at 37
◦C for 1 day
to remove the SDS.
Before staining, human CLARITY brain samples were manually cut into
pieces of approximately 2 mm3 using a scalpel.
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5.6.2 Staining and clearing of PC-processed samples
To perform immunostaining, PC processed samples were incubated at RT
for 2 days with the primary antibody (dilution, 1:50) in PBST0.1 solution,
followed by washing at RT for 1 day in PBST0.1 solution.
The tissue was then incubated with the secondary antibody (dilution,
1:50-1:100) at RT for 2 days in PBST0.1 solution, followed by washing at
RT for 1 day in PBST0.1 solution.
As primary antibodies an anti-PV (parvalbumin) antibody (Abcam, UK,
cat. ab11427 or ab64555) and an anti-GFAP (glial fibrillary acidic protein)
antibody (Abcam, cat. ab53554) were used and as secondary antibody the
Alexa Fluor 568 conjugated IgG (Abcam, cat. ab175471 or ab175704) and
the Alexa Fluor 488 conjugated IgG (Abcam, cat. ab150105) were used.
After staining, samples were optically cleared with serial incubations
in 10 ml of 20% and 47% TDE/PBS for 10 minutes at 37◦C while gently
shaking and imaged with the two-photon fluorescence microscope (described
in 5.4.2) using two color channels .
5.7 Image processing and data analysis
Light sheet fluorescence microscopy and serial two-photon tomography allow
the reconstruction of large samples at high resolution. During acquisition a
large number of data are produced.
The Terastitcher [68] tools was used to achieve a 3D image of whole
specimens from raw data. This is a stitching tool capable of dealing with
teravoxel-sized images. In collaboration with Leonardo Onofri and Giulio
Iannello (Department of Engineering, University Campus Bio-Medico of
Rome, Italy) it was used to process data acquired with both light sheet
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microscopy and two-photon fluorescence microscopy. Moreover, it was ad-
justed to analyze data acquired through serial two-photon sectioning and
was modified for double channel recording for the immunostaining images
analysis.
Graphs and data analysis were done with OriginPro 9.0 (OriginLab Cor-
poration). Image stacks were analyzed using both Fiji (http://fiji.sc/Fiji)
and Amira 5.3 (Visage Imaging) software. 3D renderings of stitched images
were produced using the Amira Voltex function. The Filament Editor of
Amira was used to trace manually neuronal filaments.
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Chapter 6
Characterization of the TDE
clearing method
The major result of this thesis is the development of a new clearing method
for multi-modal brain imaging, based on the aqueous agent 2,2'-thiodiethanol
(TDE). This chapter presents the techniques used to validate this new ap-
proach.
6.1 Measurement of light transmittance and linear
deformation
Light transmittance was determined using a spectrophotometer (Lambda
950 UV/Vis/NIR Perkin Elmer, MA) with uncleared slices in PBS as ref-
erence samples. Specimens were processed as follow.
PFA-fixed Thy1-GFP-M mouse brains were embedded in 4% agarose in
0.01 M PBS and cut into 1 mm coronal sections with a vibratome. The
agarose surrounding each half-brain slice was removed and the slices were
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cleared by serial incubations in 20%, 47%, 60%, 80% and 100% (vol/vol)
TDE/PBS, each for 1 hour in 20 ml glass vials at 37◦C while gently shaking.
Clearing with SeeDB was performed following the protocol described
by Ke et al [53]. Slices were cleared by serial incubation in 20 ml of 20%,
40% and 60% (wt/vol) fructose, each for 4-8 hours and incubated in 80%
(wt/vol) fructose for 12 hours, 100% (wt/vol) fructose for 12 hours and
finally in SeeDB (80.2% wt/wt fructose) for 24 hours while gently rotating
at RT.
For CLARITY mouse brains, a different protocol for sample prepara-
tion was followed. Since the porosity of the final gel makes samples un-
suitable for agarose embedding and vibratome cutting, 2 mm thick coronal
slices were obtained from a Thy1-GFP-M mouse CLARITY brain using a
rat brain slicer (Alto rat brain coronal matrices, CellPoint Scientific, MD).
Slices were then cleared by serial incubations in 20 ml of 20%, 47%, 63%
(vol/vol) TDE/PBS, each for 1 hour at 37◦C while gently shaking or with
FocusClearTM (CelExplorer Labs, Taiwan).
For the evaluation of linear deformation, sample photos were taken on
a glass dish filled with PBS or the respective clearing mediums. Images of
whole CLARITY mouse brains were taken with a stereomicroscope after 1
day incubation for each solution of TDE/PBS or after 3 days incubation
in FocusClearTM . Based on top view photos, the area of the samples was
determined using ImageJ/Fiji. The linear deformation was quantified by
normalizing the area of the cleared brain with the area of the brain in PBS
and calculating the square root of that quotient. To characterize possible
nonlinear distortion the edges of brain slices or whole brain were manually
traced using GIMP (www.gimp.org), resized using the linear deformation
parameter obtained before, and superimposed using different colors.
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6.2 Measurement of protein fluorescence quench-
ing and bleaching
GFP fluorescence quenching and bleaching evaluation were performed on
uncleared and cleared, PFA-fixed samples imaged with TPFM. Fixed Thy1-
GFP-M mouse brain slices of 2 mm thickness were optically cleared with
47% TDE/PBS at 37◦C. To measure the effect of quenching two-photon
images were acquired at different times and slices were incubated in 47%
TDE/PBS at RT between acquisitions. Freshly made TDE solution was
used for every measurement. The mean fluorescence intensity of homoge-
neous regions (100× 100 µm2 region of interest; ROI) was measured for each
time point using ImageJ/Fiji. Bleaching was quantified as the temporal de-
cay of the mean fluorescence intensity in a ROI enclosing a dendrite portion
(20 × 20 µm2) and the value of a neighboring area without a dendrite was
subtracted as background.
6.3 Evaluation of imaging depth
A brain slice of 2 mm thickness, from a wide-type (FVB) mouse, was in-
cubated in PBST0.5 (PBS and 0.5% triton X-100, pH 7.6) for 2 hours at
RT while gently shaking. Slices were then stained with 10 µM DAPI (4',6-
Diamidino-2-Phenylindole, Dihydrochloride, LifeTechnologies, CA, D1306)
in 3 ml PBST0.1. To compare the achievable imaging depth before and after
clearing with 47% TDE/PBS, stacks of 600 µm depth with a z step of 2
µm were acquired with TPFM. Then imaging depth was quantified by the
decay of the image contrast value with depth in cleared and uncleared sam-
ples. The image contrast of each frame was calculated with the following
equation.
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Contrast =
√∑
i(ci × (i− I)2)
C − 1 (6.1)
Where ci is the pixel count for intensity level i in an image (with i
ranging between gray levels 0 and 255). 	I = I/C is the average intensity of
the image with I defined as the image intensity integral I =
∑
i i ×ci and
C as the total pixel count C =
∑
i ci [69].
6.4 Transmission electron microscopy
Using a vibratome (Vibratome 1000 Plus, Intracel LTD, UK), sections of 500
µm thickness were cut from a Thy1-GFP-M Glut-PFA-fixed mouse brain
(the fixation protocol is described in 5.3.1). Slices were incubated in PBS
or in 47% TDE/PBS for 4 days at 37◦C while gently shaking. Samples were
washed with 50 ml of 0.01M PBS for 30 minutes and 3 times for 5 minutes
each in 20 ml of 0.1 M cacodylate buffer (pH 7.4). Post-fixation, en-bloc
staining and resin embedding for transmission electron microscopy section-
ing and imaging were performed following Knott et al [70]. A fixation of 40
minutes with 1% osmium tetroxide in 0.1M cacodylate buffer (pH 7.4) was
performed at RT. Sections were then washed twice for 5 minutes in distil-
lated water followed by 10 minutes of 1% aqueous uranyl acetate. Sections
were dehydrated in graded alcohol series (2×50%, 1×70%, 1×90%, 1×95%,
2×100%) for 3 minutes each with a final step of 10 minutes in propylene
oxide. Sections were then embedded in EPON through an incubation of 1
hour in 1:1 propylene oxide:EPON, two incubations of 30 minutes in 100%
EPON and one incubation of 4 hours in fresh 100% EPON. Finally, sec-
tions were placed in fresh EPON and incubated for 24 hours at 65◦C to
allow resin polymerization. Images were obtained with a TEM microscope
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(TEM CM 12, PHILIPS).
6.5 Hematoxylin and eosin staining
For anatomopathological characterization, formalin fixed paraffin embedded
sections from the clinical resection specimens were stained with hematoxylin
and eosin according to standard methods. To deparaffinize and rehydrate
samples, the sections were placed in a slide holder and incubated in a solu-
tion of xylene (three minutes for three times) than in ethanol 100% (3min
for 3 times), 95%and 80% 3min for 1 time, finally in deionized H2O for five
minutes. Hematoxylin staining was performed with an incubation of three
minutes, than the sample was rinsed with deionized water following by tap
water (five minutes). Destaining of not specific labeling was done with acid
ethanol followed by tap water and deionized water washing. Subsequently
eosin staining was performed for 30 seconds, then dehydration with 95%
and 100% ethanol and xylene ( three times for five minutes each) allowing
the final fixation with a coverslip and Permount.
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Part III
Results
77

Chapter 7
Characterization of clearing
agents
In the last few years, different clearing approaches have been proposed to
permit the investigation of microscopic anatomical details over whole ex-
cised organs. The purpose of this thesis is to characterize the major clearing
techniques present in literature and evaluate a new method for multi-modal
brain imaging. This chapter will present the results obtained using both
organic and aqueous solvents for brain tissue clearing.
7.1 Organic solvent clearing
Based on literature, the organic clearing methods tested in this thesis were
ethanol in combination with benzyl alcohol / benzyl benzoate (BABB, Dodt
et al. [16]) and tetrahydrofuran (THF) with dibenzyl ether (DBE, Becker
et al. [48] also called the 3DISCO method [49]).
Two parameters were used to evaluate the capabilities of the techniques:
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Figure 7.1: Comparison between organic clearing Thy1-GFP-M mouse
brains uncleared and cleared with ethanol (Et) and benzyl alcohol / benzyl
benzoate (BABB), and tetrahydrofuran (THF) in combination with diben-
zyl ether (DBE). The transparency achievable with both techniques is com-
parable, on the contrary, the protein fluorescence is better preserved in the
second method leading to a better contrast.
the transparency achievable and the fluorescence protein preservation. As
shown in figure 7.1 both the techniques reach good transparency.
It is possible to notice some tissue browning, but it doesn't affect mea-
sures significantly. On the contrary, it is possible to observe a different
protein fluorescence preservation between the two techniques. Ethanol and
BABB damaged protein fluorescence resulting in lower fluorescence inten-
sity and a high background noise. The contrast is better using THF and
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DBE as shown in figure 7.1.
The good transparency and contrast achievable with the THF/DBE
clearing method allowed to reconstruct large specimens with a light sheet
microscope. Since DBE dissolves glues used in the construction of objec-
tive lenses, a Nikon 20× air objective was used. As representative results,
some images of the cerebellum of an L7-GFP mouse are presented. Both
low-resolution images of the entire specimen and high-resolution details are
shown (figure 7.2), in particular, it is possible to observe all the Purkinje
neurons labeled with GFP.
Finally, a whole brain from an adult Thy1-GFP-M mouse, expressing
GFP in a random sparse neuronal subset, was reconstructed. LSM high-
resolution images allowed segmentation of neuronal processes. Figure 7.2
shows the reconstruction of a pyramidal neuron from the layer V of the
cerebral cortex. It is possible to recognize the dendrite arbor, the cell body,
and the axon.
7.2 TDE clearing method
After organic solvents evaluation, aqueous solutions were considered. As al-
ready discussed in the introduction each of the techniques present in litera-
ture has advantages and disadvantages that make it suitable for a particular
analysis.
However, none of the listed processes allowed the use of multiple imaging
modalities. To achieve this, a novel and versatile process to clear brain tissue
was developed.
This new clearing method is based on 2-2' thiodioethanol (TDE) [18],
a non-viscous, water-miscible compound. The refractive index (RI) of the
clearing solution can be finely tuned between that of water (1.33) and that
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Figure 7.2: LSM imaging of DBE clarified specimen (a) Panels show,
from left to right, low and high resolution images of a L7-GFP mouse cere-
bellum. Scale bar = 1000 µm, 500 µm, 200µm (b) 3D reconstruction of a
whole Thy1-GFP-M mouse brain. A pyramidal neuron from layer V of the
cerebral cortex is segmented in green. Scale bar = 1000 µm, 200 µm, 50
µm.
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of TDE (1.52) by mixing TDE with a water-based solution in varying ratios.
97% TDE was used for the first time as a mounting medium for cell cultures,
then it was applied on invertebrate [19] and intestine [20]. In this work, TDE
is used for brain tissue clearing.
7.2.1 TDE direct clearing for two-photon microscopy
The first target of the analysis was to demonstrate that TDE can be used
for sample preparation for two-photon fluorescence microscopy by a direct
clearing of the sample through the immersion of the specimen in the TDE
solution.
Based on literature and previous studies, SeeDB, a water-based optical
clearing protocol, was considered the preferred method for TDE clearing
comparison. The clearing effects of TDE were characterized in terms of
transparency and preservation of the sample.
(PFA)-fixed mouse brain sections of 1 mm thickness were incubated
in solutions of increasing percentage of TDE in phosphate-buffered saline
(PBS). TDE diffused rapidly and homogeneously through the tissue and
after few hours sections became transparent. The transmittance of TDE-
clarified samples was measured and compared with that of SeeDB (figure
7.3). Every solution showed a transmittance enhancement with longer wave-
lengths and an increasing percentage of TDE in the solution up to a percent-
age of 80% TDE/PBS. At this percentage the transmittance was comparable
with that of SeeDB-cleared samples. TDE clearing dramatically decreased
the incubation time needed for clearing slice (few hours), in comparison
with SeeDB that required weeks. Another advantage of TDE was the low
viscosity compared to that of SeeDB that makes it easy to handle.
Although, the transmittance was higher using a 80% TDE solution,
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Figure 7.3: Optical clearing with TDE (a) Transmission images and edge
tracing of 1 mm thick hemi-brain slices of Thy1-GFP-M mouse in PBS and
after clearing with various solutions. (b) Superimposed image of the edges
resized using the linear deformation parameter obtained in d, there is no
anisotropic distortion. (c) Light transmittance curves of hemi-brain slices
shown in a (mean ± s.e.m., n=4). (d) Normalized linear deformation during
optical clearing (mean ± s.d., n=4). Image modified from Costantini et al.
[71].
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to perform two-photon fluorescence microscopy (TPFM) imaging, a 47%
TDE/PBS solution was selected. It corresponds to the RI matched by
the microscope objective used for imaging (Zeiss 20× Scale objective, with
n=1.42). Using this concentration, it was demonstrated that TDE clear-
ing did not cause significant linear deformation (10% shrinkage with 47%
TDE/PBS solution) or anisotropic distortion of the tissue (figure 7.3).
Subsequently, to quantify the improvement of the imaging depth achiev-
able in cleared samples, the contrast decay was measured as a function of
depth in uncleared and cleared slices. The penetration depth with TPFM
imaging in cleared tissue was almost four times higher than in samples un-
cleared (figure 7.4).
By measuring the fluorescence decay in cleared and uncleared tissue it
was also demonstrated that incubation in TDE did not increase bleach-
ing nor did it lead to quenching of protein fluorescence (figure 7.4). The
fluorescence intensity remained constant over time, allowing long-term mea-
surements for up to two months.
At last, transmission electron microscopy (TEM) imaging was performed
to characterize the ultrastructure preservation of cleared samples (figure
7.5). TDE-treated samples were well preserved: nuclei, axons, dendrites,
vesicles and organelles could be easily distinguished. Mitochondria appeared
undamaged and ultrastructural features, such as synaptic vesicles and post-
synaptic densities, were well preserved.
7.2.2 TDE-CLARITY clearing for light sheet microscopy
Since direct TDE incubation allowed to clear only thin sections, another
protocol was developed for whole brain imaging. TDE was combined with
the CLARITY method for light sheet microscopy analysis. Indeed, to obtain
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Figure 7.4: Characterization of TDE clearing (a) Two-photon fluores-
cence imaging of 2 mm FVB mouse brain slices stained with DAPI in PBS
and in 47% TDE/PBS. Reconstruction along z-axis, depth 1 mm; scale bar
= 100 µm. (b) Contrast decay as function of depth in uncleared and cleared
samples (mean± s.d., n=10). (c) Half-time fluorescence decay (mean± s.d.,
n=4); clearing did not increase photobleaching compared to PBS. (d) Flu-
orescence intensity over time (mean ± s.d., n=10); no quenching effect was
observed after incubation of the sample in 47% TDE/PBS for up to two
months. Image modified from Costantini et al. [71].
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Figure 7.5: Transmission electron microscopy Images of Thy1-GFP-
M mouse brain slices previously incubated in PBS and in 47% TDE/PBS
for 4 days. Triangles indicate mitochondria (red), axons (green) and nuclei
(blue). Scale bar = 2 µm (upper panels) and 200 nm (lower panels). Image
taken from Costantini et al. [71].
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an inexpensive tool to expand the applicability of light sheet microscopy,
TDE was used as clearing agent instead of FocusClearTM for the CLARITY
protocol.
In order to match the correct refractive index (RI=1.45), a 63% TDE/PBS
solution was selected. Entire CLARITY mouse brains were made uniformly
transparent, and the transmittance was compared to that of FocusClearTM .
Moreover, the linear deformation and the anisotropic distortion of the tissue
caused by the clearing were studied (figure 7.6).
During the analysis also the electrophoretic step of the CLARITY pro-
tocol was considered. During this step the tissue expands and then it comes
back to the original size after clearing, producing a transient swelling. Tis-
sue linear deformation caused by clearing with TDE and with FocusClearTM
was measured and compared. As result, it was noticed that TDE, similarly
to FocusClearTM , shrank the tissue back producing a final tissue expansion
of 16% without introducing anisotropic distortion (figure 7.6).
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Figure 7.6: Combination of the TDE clearing with the CLARITY
protocol (a) Transmission images and edge tracing of a Thy1-GFP-M
mouse brain after CLARITY protocol: hydrogel-tissue hybridization and
lipid removal with ETC, clearing with various solutions. (b) Superimposed
image of the edges resized using the linear deformation parameter obtained
in d, there is no anisotropic distortion. (c) The light transmittance of 2 mm
CLARITY brain slices in different solutions (mean ± s.e.m, n=4). Trans-
mittance increased with the RI and that of 63% TDE/PBS is comparable
to that of FocusClearTM . (d) Normalized linear deformation of CLARITY
brains in different solutions (mean ± s.d, n=4). After initial expansion due
to the ETC lipid removal, the tissue shrank back to its original size during
the clearing step. Image modified from Costantini et al. [71].
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Chapter 8
Mouse brain imaging with
TDE clearing
TDE clearing, with or without the combination with the CLARITY proto-
col, was used to prepare specimens for serial two-photon tomography and
light sheet microscopy. In particular, it was used to reduce the imaging
time necessary to reconstruct a large tissue volume allowing fast analysis of
mouse brain anatomy. This chapter will present the results obtained using
the TDE clearing protocol for STP and LSM imaging.
8.1 Serial two-photon tomography
The direct TDE clearing was exploited to expand the imaging depth achiev-
able with the serial two-photon tomography technique (STP). TDE clearing
enhanced the penetration depth achievable with TPFM. Thus it allowed to
reduce tissue slicing, decreased the acquisition time, minimized cut arti-
facts and enabled lossless whole sample imaging compared to the classic
91
92 Chapter 8. Mouse brain imaging with TDE clearing
STP used by Ragan et al. [14].
To demonstrate the capabilities of direct TDE clearing, an entire mouse
hippocampus dissected from a fixed adult Thy1-GFP-M mouse brain was
reconstructed. The hippocampus was imaged with TPFM using a Zeiss 20×
Scale objective (figure 8.1).
Through this complete tomography, specific anatomical features of the
hippocampus, such as dentate gyrus and Cornu Ammonis areas, were easily
recognizable (figure 8.2). Moreover, the high-resolution stacks acquired in
this tomography could reveal fine anatomical details of the sample such as
spines and varicosities.
The high sensitivity of this approach enabled the complete tracing of
single neurons through a large volume without interpolation as shown in
figure 8.3.
8.2 Light sheet microscopy
After demonstrating the possibility of performing complete reconstruction
of large volumes at high resolution, the aim of the work was addressed at
getting an expanded view of morphological details over the whole mouse
brain. The strength of the TDE clearing is the versatility that make it
suitable for correlative approaches.
LSM, combined with suitable clearing techniques, has the potential of
imaging big volumes of tissue in short time. Brains from different mouse
lines were thus processed with CLARITY and cleared with TDE in order
to imaged them with LSM.
At first an adult PV-cre-tdTomato mouse brain, in which parvabumin-
ergic neurons are labeled with the tdTomato fluorescent protein, was re-
constructed with sub-cellular resolution. As shown in figure 8.4 the main
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Figure 8.1: Hippocampus tomography Reconstruction of entire Thy1-
GFP-M mouse hippocampus fixed with PFA and cleared with 47%
TDE/4PBS (Zeiss 20× Scale objective, two-photon excitation). 3D ren-
dering of six layers of 1 mm thickness each sampled every 4 µm. Serial
sectioning at 800 µm depth. The scale of the figure can be inferred from
the white cube in the bottom right corner which has 300 µm side. Image
taken from Costantini et al. [71].
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Figure 8.2: Hippocampus high resolution images (a) Coronal section
corresponding to the yellow box in 8.1. It is possible to recognize the dentate
gyrus (DG) and the Cornu Ammonis areas (CA1 and CA3); scale bar =
300 µm. (b) Single image at full resolution of one stack showing some
dendritic and axonal fibers; scale bar = 50 µm. (c) and (d) Magnified inserts
corresponding to red boxes in c. Red triangles highlight axon varicosities
and dendritic spines; scale bar = 10 µm. Image taken from Costantini et
al. [71].
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Figure 8.3: Neuron tracing Three-dimensional tracing of single neurons
through different stacks and layers of the hippocampus shown in 8.1. Image
a shows a maximum intensity projection of a volume of 400 µm, while in b
there are only the neuron tracks. Scale bar = 300 µm. Image taken from
Costantini et al. [71].
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anatomical features can be easily dissected and the distribution of cells
bodies and axonal bundles can be visualized over the whole brain.
The preservation of the sample was also maintained in a GAD2-cre-
tdTomato mouse brain, in which GABAergic interneurons are labeled, show-
ing finer details of the neuronal connections (figure 8.5). To further test the
compatibility of this clearing method with organic dyes, a mouse brain la-
beled with the nuclear cell marker propidium iodide was imaged (figure 8.5).
The fluorescence of this molecule was retained over the whole brain. In fu-
ture, this could be used to provide valuable data for automatic cell body
counting algorithms [72].
Finally, brain vasculature (previously labeled with FITC-albumin) was
imaged. This approach revealed even the smaller capillaries, allowing access
to large volumetric reconstructions of the mouse vasculature (figure 8.5).
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Figure 8.4: Whole mouse brain tomography Imaging of whole PV-
tdTomato transgenic mouse brains treated with CLARITY and cleared with
63% TDE/PBS imaged with LSM (Olympus, 25× objective). Image taken
from [71].
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Figure 8.5: LSM mouse brains imaging (a) 3D rendering of stacks from
a PV-tdTomato mouse brain, a GAD-tdTomato mouse brain, a PI stained
mouse brain, and aFITC-albumin labeled mouse brain, scale bar = 400 µm.
(b,c,d,e) High-resolution inserts of stack corresponding to red boxes in a.
Scale bar = 100 µm. Image taken from [71].
Chapter 9
Human brain imaging
After demonstrating the general applicability of the TDE method on ani-
mal models, its translational potential was investigated on human samples.
Human brain studies present various challenges. This chapter will describe
some of them. In particular, sample preparation, large tissue labeling, sam-
ple clearing, and imaging will be described.
9.1 Tissue immunostaining
Human brain analysis with fluorescence microscopy requires an ex vivo la-
beling. A technique that allows specific labeling is immunohistochemistry
(IHC). Usually, it is performed on thin slices (10 µm thick) because the
membrane lipid double-layer prevents antibody penetration into tissues.
CLARITY overcomes this limitation by removing lipids, allowing IHC on
large samples. To permit thick brain tissue labeling with immunohisto-
chemistry, the compatibility of TDE clearing with the use of antibodies was
investigated.
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At first, the compatibility of TDE clearing with immunohistochemistry
was tested on mouse brain tissue. A slice of a PFA-fixed Thy1-GFP-M
mouse brain was treated with the passive CLARITY (PC) method [21]. The
sample preparation used in this protocol allowed to obtain the CLARITY
hydrogel without the direct perfusion of acrylamide. Proteins are embedded
in the gel while lipids are removed with passive clearing.
The sample was labeled with an Alexa Fluor 594 conjugated anti-GFP
antibody and then cleared with the 47% TDE/PBS solution before TPFM
imaging. GFP and Alexa Fluor signals colocalized showing that the labeling
was well performed. The characteristic features of GFP-expressing neurons
(for example dendritic spines) were easily recognizable in the TPFM images
(figure 9.1), suggesting that the 47% TDE/PBS solution did not affect the
protein-antibody interaction.
After proving that TDE is a valid clearing medium for mouse IHC
stained tissue, the protocol was applied on human brain samples.
A large specimen surgically removed from a patient with drug resistant
epilepsy due to hemimegalencephaly (HME) was studied. The sample ex-
hibiting the severe form of cortical dysplasia suits the purpose of testing
the method's sensitivity in highlighting different elements of an abnormal
cytoarchitectonic organization.
In particular, a 2-mm thick block of the cortex, stored in formalin, was
treated with the PC technique, stained with different antibodies and cleared
with TDE solution. The tissue was successfully labeled with antibodies
against parvalbumin (PV) and glial fibrillary acidic protein (GFAP) as well
as a double labeling with the combination of them (figure 9.2).
The CLARITY method allows multi-round analysis on mouse brain. In
this work it was successfully adapted to human brain tissue analysis. Indeed,
a 2-mm thick block of the cortex was labeled with anti-PV antibody, cleared
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Figure 9.1: Mouse brain immunostaining TDE-CLARITY clearing is
compatible with IHC. (a) GFP fluorescence (green); (b) Alexa Fluor 594
anti-GFP antibody (red); (c) overlay. Scale bar = 50 µm (upper panels)
and 10 µm (lower panels). Image taken from Costantini et al. [71].
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Figure 9.2: Multiple immunostaining Human brain labeling with differ-
ent antibodies. (a) Parvalbumin (PV) staining in red and nuclei (DAPI) in
cyan; scale bar = 100 µm. (b) Glial fibrillary acidic protein (GFAP) stain-
ing in yellow and nuclei (DAPI) in cyan; scale bar = 100 µm. (c) GFAP
staining in yellow and PV in red; scale bar = 100 µm. Image taken from
[71].
with TDE and imaged with TPFM, and then PV antibodies were removed
and the tissue was stained again with anti-GFAP antibodies and imaged
with TPFM (figure 9.3).
9.2 Three-dimensional reconstruction of the cortex
of a patient with hemimegalencephaly
The development of the cerebral cortex is a complexly organized process.
Disruption of any of the steps that contribute to this process (neuronal
proliferation, migration or layer organization), can result in a wide range of
developmental disorders.
Many of these disorders are recognized as malformations of cortical de-
velopment (MCD). MCD encompasses a wide spectrum of focal and diffuse
disorders with various underlying genetic etiologies and clinical manifesta-
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Figure 9.3: Multi-round immunostaining (a) Parvalbumin (PV) stain-
ing in red and nuclei (DAPI) in green; scale bar = 100 µm. (b) Glial
fibrillary acidic protein (GFAP) staining in red and nuclei (DAPI) in green;
scale bar = 100 µm.
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tions [73, 74, 75]. Hemimegalencephaly (HME), first described by Sims in
1835 [76], also known as unilateral megalencephaly, is a malformation of
the cortex, that occurs during the early development and is characterized
by the enlargement of one cerebral hemisphere (figure 9.4) [77, 78, 79].
An HME cerebral cortex presents several histopathological abnormali-
ties: dyslamination, dysmorphic immature neurons and balloon cells, indi-
cating primary defects in neuroglial differentiation, migration and cellular
growth [73]. HME is considered to be a primary disorder of proliferation
wherein the neurons that are unable to form synaptic connections are not
eliminated but accumulated [73]. The affected hemisphere may also have
focal or diffuse neuronal and glial cell migration defects. The exact patho-
genesis of such a complex malformation is still unknown.
Individuals with HME typically present epilepsy, psychomotor disabil-
ity, contralateral hemiparesis, and hemianopsia. Treatments may lessen or
alleviate seizures and improve the quality of life for HME patients. In most
cases, the first line of treatment is AEDs (Anti-Epileptic Drugs), though
many children experience significant benefit from hemispherectomy. Hemi-
spherectomy is the most effective treatment to control seizures, and it also
seems to provide good results on the psychomotor development when per-
formed early [80].
After proving the compatibility of TDE clearing with PC and IHC, the
protocol was used to characterized the specimen removed from a patient
with drug resistant epilepsy due to hemimegalencephaly (HME). In partic-
ular alterations of the cerebral cortex were imaged and three-dimensional
information on neuronal organization were obtained.
To validate the process, dysplastic tissue images obtained with the new
protocol were compared with that of routine anatomopathological char-
acterization. This evaluation allowed a direct comparison between con-
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Figure 9.4: MRIs of a patient with hemimegalencephaly (HME)
(a,b) Coronal and axial MRI images showing a normal brain. (c,d) MRI
images from the brain of a patient with HME, before the surgical removal
of the left-sided abnormal hemisphere. (e,f) Images of the brain after left
hemispherectomy. Cerebrospinal fluid fills the space where the abnormal
hemisphere had been. From [79].
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Figure 9.5: Human brain histology (a) Hematoxylin/eosin staining of
paraffin embedded tissue (b) Two-photon imaging of the sample treated
with the passive-CLARITY protocol, cleared with TDE and immunostained
with anti-parvalbumin (in red) and nuclei marker (DAPI, in cyan). White
arrows indicate giant dysmorphic neurons, white arrowheads indicate wild-
type neurons. Scale bar = 50 µm. Image taken from [71].
ventional hematoxylin/eosin staining and the immunostaining obtained on
TDE-CLARITY cleared sample.
Giant dysmorphic neurons were identified using both staining tech-
niques, remarking that the features observed in the cleared tissue were
directly comparable to those obtained by conventional staining techniques
(figure 9.5).
To obtain three-dimensional information of the dysplastic tissue a cube
of 1 mm3 was prepared and imaged with TPFM. The staining was performed
with an antibody against parvalbumin in combination with DAPI (figure
9.6). To analyze the homogeneity of the labeling through the tissue during
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Figure 9.6: Human brain 3D reconstruction 2 mm thick block of
formalin-fixed tissue removed from the dysplastic hemisphere of a patient
with hemimegalencephaly, treated with PC CLARITY protocol, immunos-
tained and cleared with 47% TDE/PBS (Zeiss 20× Scale objective, two-
photon excitation).(a,b) 3D rendering of a 1 × 1 × 1 mm3 and 0.25 × 0.25
× 1 mm3 section of brain tissue labeled for PV (red) and DAPI (cyan). (c)
Horizontal view of sections of b at different depths; scale bar = 100 µm.
Image taken from [71].
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imaging the same contrast was maintained through out the whole depth.
The result showed that optimization of the PC staining protocol with the
introduction of the TDE clearing allowed augmenting the penetration depth
of the antibody by 100% compared to the data of Chung et al [21].
No alterations in signal intensity were observed over the entire depth.
Moreover, single axons could be easily recognized in the densely labeled sam-
ple. Tracing of neurons could be performed across the entire volume (figure
9.7). Isolated neuronal processes could be clearly distinguished, demonstrat-
ing that projections can now be studied by tracing neurites over a mm-sized
volume.
Finally, the structural alteration of the whole cortex of the HME pa-
tient was observed. The PV-stained tissue was imaged, and a mosaic was
performed starting from the gray matter and ending at the white mat-
ter. Figure 9.8 shows the organization of neuronal fibers: the gray matter
presents a high concentration of strands, the white matter, instead, is con-
stituted by well organized fibers. Indeed, it is possible to observe by eyes
their precise orientation. It is also possible to identify some dimorphic cells
body, mainly located 3 mm below the gray matter.
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Figure 9.7: Neuronal tracing Three-dimensional tracing of parvalbumin
fibers through the volume shown in 9.6. Scale bar = 200 µm. Image taken
from [71].
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Chapter 10
Discussion
Commonly, optical dissection of brain architecture is addressed with differ-
ent microscopy techniques coupled with various sample preparation meth-
ods. In this respect, several clearing protocols have been developed to re-
duce light scattering during imaging. Table 10.1 summarizes the major
techniques developed in the last years based on both organic and aqueous
solutions. However, each of them has distinctive characteristics which makes
it suitable for a specific optical technique while limiting its use for comple-
mentary ones. These characteristics confine the research to a specific field,
preventing the possibility of using multi-modal approaches. Although these
techniques can study specific questions, they are not enough to address the
connectomics challenge. Indeed, to do that it is necessary to combine differ-
ent methods and integrate the data obtained with various techniques. The
purpose of this thesis is exactly obtaining a tool that facilitates correlative
approaches. In this chapter the results obtained in this respect are discussed
with the help of the current literature.
The evaluation of organic solvents clearing confirms what was suggested
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in the work of Becker et al. [48]. Tetrahydrofuran with dibenzyl ether
is indeed the best combination of dehydration and clearing solvents used
to prepare samples. This approach allows for imaging samples with good
resolution, moreover, it is fast and easy to perform, and it can be applied
to immunolabelled samples (as shown in the iDISCO techniques [50]).
However, it presents some limitation: first of all, after a few days the
protein fluorescence is quenched, making long measurements unfeasible in
transgenic animals with normal fluorescent protein expression levels. Sec-
ondly, the process is irreversible: every sample can be used only for one
type of study, it is not possible to analyze the sample with different tech-
niques. Eventually, DBE dissolves glues used in the construction of objective
lenses, preventing the use of immersion objectives that avoid aberrations in-
troduced by the air/solvent interface. The absence of commercial corrected
objectives for DBE [81] limits the quality of the acquired images affecting
the results.
To overcome the limitations found using the organic solvent clearing,
this thesis faced the development of a simple, quick and inexpensive clear-
ing method for multi-modal brain imaging. The method was based on a
refractive index matching agent called 2,2'-thiodiethanol (TDE) [18].
The first application consisted in the direct incubation of samples in
TDE solutions for two-photon fluorescence microscopy. The TDE clearing
was compared with another method present in literature, the SeeDB [53]
technique. It was considered a better clearing techniques compared to oth-
ers (table 10.1), because SeeDB does not introduce tissue deformation and
preserves fluorescence of the sample.
The clearing characterization, performed on PFA-fixed tissue, was based
on several criteria. Resulting transparency in terms of light transmit-
tance, protein fluorescence quenching and bleaching, linear deformation and
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anisotropic distortion of the tissue. Tests showed that the transparency at-
tainable was comparable with that of SeeDB. It depended on the RI of
the solution and, therefore, on the increasing concentration of TDE in the
solutions. In particular, the imaging depth achievable after the clearing
procedure was increased by a factor of four in PFA-fixed samples compared
with uncleared tissues.
During the process, clearing did not substantially change the final vol-
ume of the specimen, nor did it lead to linear deformation or anisotropic
distortion. Moreover protein fluorescence of the sample remained constant
over time during long-term incubations, even up to months, indicating that
the clearing protocol does not lead to quenching. Also, it did not lead
to fluorescence bleaching, therefore, it is suitable for the study of protein
endogenous fluorescence in transgenic animals conversely to the organic sol-
vent techniques [16] [48]. Nevertheless TDE diffuses quickly inside the brain
tissue, allowing a fast and easy clearing procedure compared with other
techniques such as, for example, Scale [51] or SeeDB [53] (see table 10.1).
Finally, a very important characteristic of TDE is the low-viscosity of the
solutions. It allows easy sample sectioning, making TDE clearing suitable
for the complete reconstruction of large brain areas using serial two-photon
tomography (STP). On the contrary, the SeeDB method is incompatible
with STP due to its high viscosity. This limits the acquisition of 3D volumes
to the imaging depth reached by the microscope.
The advantages given by the TDE direct clearing were used to study an
entire PFA-fixed Thy1-GFP-M mouse hippocampus. The combination of
acquired stacks using an automatic 3D-stitching tool allowed to trace single
neuronal processes with high accuracy throughout entire volume. Thanks
to the reconstruction of the tomography, every individual part of the hip-
pocampus was imaged at high resolution, giving the possibility to resolve
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spines and varicosities across the whole area.
TDE direct clearing, however, is not suitable for the imaging of entire
organs without cutting. Hence to overcome this limit and to obtain an
optimum transparency in the whole mouse brain, TDE was coupled with
the CLARITY technique [21] to allow imaging with light sheet microscopy.
It was demonstrated that TDE is a valid alternative to FocusClearTM as
refractive index matching solution. It considerably lowers the cost of every
experiment and makes affordable large-volume, high-throughput imaging
with LSM possible.
Moreover, the unknown composition of FocusClearTM impaired any ef-
fort of the scientific community to further improve its clearing efficiency.
Instead, TDE permits the integration of other compounds that can poten-
tially improve the optical transparency of the selected specimen. Moreover
the refractive index variation achievable by different TDE/PBS percentages
allows an ad hoc optimization of the clearing capability of the method for
different tissue types.
To demonstrate the applicability of the TDE-CLARITY protocol, mouse
brains labeled with different dyes were imaged with LSM. Both neurons
and vessels were studied, as well as cell nuclei and fibers. The different
applications underline how TDE can be used for various analysis, from
the three dimensional organization of a subpopulation of neurons (e.g. the
parvalbuminergic or the GABAergic system) to the localization of every cell
of the brain, but also the arrangement of the vascular system.
Finally, the compatibility of TDE clearing with immunostaining on brain
tissue from different species was studied, namely on mouse brain and hu-
man brain samples. The protocol was implemented for formalin-fixed sam-
ples and combined with the passive CLARITY. A 1 mm3 cube of tissue
from a hemimegalencephaly patient was homogenously stained with differ-
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ent antibodies and imaged with TPFM. Dysplastic neurons, characteristic
of the disease [73], were recognized; moreover, neuronal fibers were followed
throughout the whole volume.
The capability of performing immunochemistry in a large volume of
human brain tissue with micrometric resolution and high sensitivity is a
crucial step in the direction of human brain connectomics. Moreover, it
represents an innovative translational tool to characterize macroscopic and
microscopic circuit alterations and to identify cells having aberrant mor-
phology, that are a common finding in brains of individuals with refractory
epilepsy, intellectual disability, and autism.
In conclusion, compared with other techniques, the TDE protocol cov-
ers a wide range of applications. The most intriguing characteristic of this
method lies in its versatility; the possibility to choose the most suitable
tool for different experiments permits a powerful investigation of neuronal
networks in the brain. As a matter of fact, TDE can facilitate correlative
approaches and help to overcome the inherent limitations of a single imag-
ing technique, enabling multi-modal approaches for brain anatomy studies
[82, 83]. It can, definitely, contribute to enhancing the understanding of
anatomic structure and connectomics of the brain.
For the future, the usefulness of TDE may not be limited only to brain
neuroanatomy investigations but, as shown by other clearing methods, could
also span different areas of research such as entomology [16] [84], embryology
[48] [15] and even medicine with 3D anatomical studies of biopsies from
different organs and tissues [21].
Chapter 11
Future prospective
The work of this thesis approaches the connectomics challenge by expanding
the possibility of performing multi-modal analysis on mouse and human
brains. However, to obtain a complete view of the brain a lot of work
remains to be done. This chapter describes some improvements that could
be accomplished in the near future that will facilitate anatomical analysis.
As first analysis, the limitations of the TDE technique in the field of
human brain imaging needs to be explored. In particular, to expand the
human study, future work should regard the maximum sample thickness
achievable with the immunostaining technique. The best compromise be-
tween contrast (which is limited by the penetration depth of antibodies) and
sample throughput should be studied. After that, using the optimized TDE
technique the neurons organization will be mapped in healthy and patho-
logical human brains. Through the development of a software for automatic
cell localization and tracing the differences between samples will be studied
and quantitative data will be obtained. That will give the possibility to
exploit new diagnostic methods based on three-dimensional analysis.
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Thanks to great advances in optics, different microscopes are now com-
mercially available, leading to the necessity of having useful techniques for
sample preparation. In particular, clearing procedures, as the one presented
in this work, are crucial in obtaining high tissue transparency while preserv-
ing sample fluorescence. Up to now a lot of different approaches have been
explored, however, for the future, the main goal to pursue will be the stan-
dardization of protocols, rather than the development of new ones. Indeed,
commercial kits could remove systematic errors obtaining more reliable re-
sults [85].
In parallel, other potential developments concern the correction of light
scattering within the microscope. In fact, instead of operating only on sam-
ple preparation, it can be possible to correct aberration using techniques
such as adaptive optics. The combination of adaptive optics with sample
clearing will increase acquisition speed, will extend imaging depth penetra-
tion and will improve the spatial resolution of future optical microscopes
[86, 87].
Another big challenge of neuroanatomy reconstruction regards sample
labeling. Transgenic fluorescent animal models are widely used to study
brain structures. However, the use of genetically encoded fluorescent indi-
cators is limited to a few animal models and requires complex genetic en-
gineering procedures. To expand fluorescence microscopy to different types
of samples, such as a pathological model or human brain, it is necessary
to develop new techniques. Antibodies and nucleic acids conjugated with
fluorescent indicators may be used to access all different kinds of specimen.
They should be optimized to better access epitopes deep inside samples
in a short period of time. A promising recent development in this field is
the engineering of nucleic acid aptamers and single-domain antibodies [88].
Additionally, new methods can be developed to substitute the passive dif-
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fusion of molecules inside tissue, for example, active transport can facilitate
penetration making the labeling fast and uniform [89].
A different important aspect that will require a lot of effort regards the
management of the large data sets obtained with image acquisitions. 3D
reconstructions of whole specimens from raw data as well as analysis and
comparison between different massive volumetric data sets take a consider-
able amount of processing time and computational memory. To achieve a
global organization of the information, it will be necessary to develop novel
technologies as for massive data collection, data sharing, and multi-modal
integration so to achieve statistically robust conclusions [90].
Finally, to obtain a complete view of the brain, efforts need to be focused
on correlation with functional analysis. Structural reconstruction can't give
all the information necessary to understand how the brain works. It is ex-
tremely important to integrate it with functional maps of brain circuitry
that can now be achieved at the mesoscale level with approaches such as
MRI [91, 92, 93] which can investigate the connections between different
brain areas. Moreover, electrophysiological analysis of single neuronal ac-
tivity can be done with electrodes or through the combination of optogenetic
technology [94, 95] with optical recording mediated by voltage sensitive dyes
or calcium indicators.
Such efforts are highly informative, indeed, to comprehend how neural
circuits process information and generate behavior, it will be necessary to
connect all the different studies. When a high level of spatial and temporal
resolution analysis will be collected in one single map, the connectomics
challenge could eventually be solved.
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